Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 59
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Clinical effectiveness and bacteriological eradication of three different Short-COurse antibiotic regimens and single-dose fosfomycin for uncomplicated lower Urinary Tract infections in adult women (SCOUT study), study protocol for a randomised clinical trial

  • García Sangenís, Ana|||0000-0002-6689-6466
  • Morros, Rosa|||0000-0001-6752-8748
  • Aguilar-Sánchez, Mercedes
  • Medina-Perucha, Laura|||0000-0002-2981-2614
  • Leiva, Alfonso|||0000-0001-5306-8533
  • Ripoll, Joana|||0000-0002-5251-7234
  • Martínez-Pecharromán, Mar
  • Bartolomé-Moreno, Cruz B.
  • Magallon Botaya, Rosa|||0000-0002-5494-6550
  • Marín-Cañada, Jaime
  • Molero, José M.|||0000-0002-4426-2593
  • Moragas, Ana
  • Troncoso, Amelia
  • Monfà, Ramon|||0000-0002-1324-3971
  • Llor, Carl|||0000-0001-6644-717X
Uncomplicated lower urinary tract infections (uLUTI) are a common problem in primary care. Current local guidelines recommend the use of a single 3 g dose of fosfomycin. However, most general practitioners (GP) prefer short-course therapies to single-dose therapy. No study has compared head-to-head short-course antimicrobial agents for uLUTIs. Therefore, the aim of this randomised clinical trial is to compare three different short-course antibiotic therapies with a single-dose of fosfomycin for these infections. This will be a pragmatic, multicentre, parallel group, open trial. Women aged 18 or older and with symptoms of uLUTI and a positive urine dipstick analysis will be randomised to one of the following four groups: a single dose of 3 g of fosfomycin, 2 days of 3 g of fosfomycin o.d., 3 days of pivmecillinam 400 mg three times per day (t.i.d) or 5 days of nitrofurantoin 100 mg t.i.d. A total sample of 1120 patients was calculated. The primary endpoint is clinical effectiveness at day 7, defined as cure of symptoms reported by the patients in a diary including four symptoms: dysuria, urgency, frequency and suprapubic pain, which will be scored on a 4-point severity scale (not present/mild/moderate/severe). Follow-up visits are scheduled at days 7 (phone call), 14 and 28 for assessing evolution. Urine samples will be collected in the three on-site visits and urine cultures performed. If positive, antibiograms for the three antibiotics studied will be performed. Bacterial eradication will be measured at days 14 and 28. The study was approved by the Ethical Board of IDIAP Jordi Gol (reference number: 21/173-AC) and Spanish Agency of Medicines and Medical Devices. The findings of this trial will be disseminated through research conferences and peer-review journals. ; EudraCT Number: 2021-001332-26. January 2022 to April 2023.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Applying a School-Based Mindfulness and Compassion Program ("Escuelas Despiertas") in Spanish Secondary Schools to Reduce Psychological Distress in Adolescents, A Randomized Controlled Trial

  • Aguilera, Pilar
  • Navarro, Mayte
  • Pérez-Aranda, Adrián|||0000-0002-1602-3413
  • Armas Landata, Carilene Enelram
  • Beltrán-Ruiz, María|||0000-0003-0786-535X
  • Rodríguez Freire, Carla|||0009-0006-6728-5778
  • Camarero-Grados, L.
  • Garcia-Campayo, Javier|||0000-0002-3797-4218
  • Montero-Marín, Jesús|||0000-0001-5677-1662
Adolescents present high risk of developing mental health problems. Different school-based programs have been designed to prevent and treat the psychological distress that they often experience with disparate results. In this study, we tested the efficacy of a school-based program framed into the "Escuelas Despiertas" initiative that teaches adolescents mindfulness and compassion to improve their mental health. In this randomized controlled trial, high school students from four Spanish secondary education centers (N = 277) were randomly assigned to a school-based 10-session mindfulness and compassion program ("Escuelas Despiertas") or a relaxation program. Participants were assessed at baseline, posttreatment, and at 6-month follow-up. The main outcome was psychological distress (General Health Questionnaire, GHQ-12). Classroom climate and relaxation habits, among others, were assessed as secondary outcomes. Students who underwent the "Escuelas Despiertas" program experienced small within group improvements posttreatment in GHQ-12 scores (p = 0.001, d = 0.31) and in relaxation habits (p = 0.001, d = 0.35), although these were not significant compared to the control group. Classroom climate presented a small deterioration in the "Escuelas Despiertas" group compared to the relaxation group in the follow-up assessment, but this effect was not statistically significant after correcting for multiple comparisons. In conclusion, the "Escuelas Despiertas" program produced small short-term improvements in psychological distress and relaxation habits in adolescents which were not significant compared to a relaxation intervention. In line with previous studies, it seems that punctual interventions delivered during some weeks might not be the best approach for adolescents, for whom mindfulness- and-compassion-based programs may not be engaging enough for different reasons.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A systematic review of cognitive behavioral therapy-based interventions for comorbid chronic pain and clinically relevant psychological distress

  • Sanabria-Mazo, Juan P.|||0000-0003-1688-435X
  • Colomer-Carbonell, Ariadna|||0000-0001-8923-6316
  • Fernández-Vázquez, Óscar
  • Noboa-Rocamora, Georgina
  • Cardona-Ros, Gemma
  • McCracken, Lance M.|||0000-0002-9734-0153
  • Montes-Pérez, Antonio
  • Castaño Asins, Juan Ramon|||0000-0001-6571-503X
  • Edo Izquierdo, Sílvia|||0000-0002-6564-3475
  • Borràs, Xavier|||0000-0003-3972-1385
  • Sanz Ruiz, Antoni|||0000-0002-7952-4477
  • Feliu-Soler, Albert|||0000-0003-2810-7670
  • Luciano, Juan Vicente|||0000-0003-0750-1599
Chronic pain frequently co-occurs with clinically relevant psychological distress. A systematic review was conducted to identify the efficacy of cognitive behavioral therapy-based interventions for patients with these comorbid conditions. The systematic search was carried out in Medline, PsycINFO, Web of Science, and Scopus up to March 18th, 2023. Four reviewers independently conducted screenings, extraction, and quality assessment. Twelve randomized controlled trials and one non-randomized controlled trial involving 1,661 participants that examined the efficacy of Cognitive Behavioral Therapy (nine studies), Mindfulness-based Interventions (three studies), Acceptance and Commitment Therapy (one study), and Behavioral Activation Therapy for Depression (one study) were included. Compared to treatment as usual, six out of eight studies of traditional Cognitive Behavioral Therapy reported significant differences in the reduction of depressive symptoms at post-treatment (d from 1.31 to 0.18) and four out of six at follow-up (d from 0.75 to 0.26); similarly, five out of six reported significant differences in the reduction of anxiety symptoms at post-treatment (d from 1.08 to 0.19) and three out of four at follow-up (d from 1.07 to 0.27). Overall, no significant differences between traditional Cognitive Behavioral Therapy and treatment as usual were reported at post-treatment and follow-up in the studies exploring pain intensity and pain catastrophizing. The available evidence suggests that traditional Cognitive Behavioral Therapy may produce significant benefits for the improvement of depression, anxiety, and quality of life, but not for pain intensity and pain catastrophizing. More evidence is needed to determine the effects of MBI, ACT, and BATD.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Complications of oropharyngeal dysphagia in older individuals and patients with neurological disorders, insights from Mataró hospital, Catalonia, Spain

  • Karunaratne, Tennekoon B.|||0000-0002-5918-5738
  • Clavé i Civit, Pere|||0000-0002-0696-8560
  • Ortega, Omar|||0000-0001-6178-3748
Background: Oropharyngeal dysphagia (OD) significantly impacts older individuals and neurologically compromised patients, hindering safe ingestion of food and liquids. Despite its prevalence, OD remains underdiagnosed and undertreated, leading to severe complications such as malnutrition, dehydration, respiratory infections, and aspiration pneumonia (AP), and increases hospital readmissions. Objectives: This study analyzes the intricate relationship between OD and various clinical complications in older individuals and patients with neurological disorders. Methods: Utilizing retrospective analysis and narrative review, our work consolidates findings from prior studies on Hospital de Mataro's dysphagia patient cohort. Revisiting OD's intricate association with clinical complications, it presents data via odds ratios (OR), incidence ratios (IR), and hazard ratios (HR) from univariate and multivariate analyses. Results: Five studies (2001-2014) involving 3,328 patients were scrutinized. OD exhibited independent and significant associations with various complications among older patients. Older individuals with OD faced heightened 1-month (ODDS 3.28) and 1-year (OR 3.42) mortality risks post-pneumonia diagnosis. OD correlated with a 2.72-fold risk of malnutrition, 2.39-fold risk of lower respiratory tract infections, 1.82-fold pneumonia readmissions (IR), and 5.07-fold AP readmissions (IR). Post-stroke OD is linked to neurological impairment (OR 3.38) and respiratory (OR 9.54) and urinary infections (OR 7.77), alongside extended hospital stays (beta coefficient 2.11). Conclusion: Oropharyngeal dysphagia causes and significantly exacerbates diverse clinical complications in older and post-stroke patients, emphasizing the urgent need for proactive identification, comprehensive assessment, and tailored management. Acknowledging OD's broader implications in general medical practice is pivotal to improving patient outcomes and healthcare quality.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Inflammation, The Link between Neural and Vascular Impairment in the Diabetic Retina and Therapeutic Implications

  • Ramos, Hugo|||0000-0001-6443-7576
  • Hernández, Cristina|||0000-0002-3109-1721
  • Simó Canonge, Rafael|||0000-0003-0475-3096
  • Simó-Servat, Olga|||0000-0003-3483-652X
The etiology of diabetic retinopathy (DR) is complex, multifactorial and compromises all the elements of the retinal neurovascular unit (NVU). This diabetic complication has a chronic low-grade inflammatory component involving multiple inflammatory mediators and adhesion molecules. The diabetic milieu promotes reactive gliosis, pro-inflammatory cytokine production and leukocyte recruitment, which contribute to the disruption of the blood retinal barrier. The understanding and the continuous research of the mechanisms behind the strong inflammatory component of the disease allows the design of new therapeutic strategies to address this unmet medical need. In this context, the aim of this review article is to recapitulate the latest research on the role of inflammation in DR and to discuss the efficacy of currently administered anti-inflammatory treatments and those still under development.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Vitamin D Supplementation Is Associated with Inflammation Amelioration and Cognitive Improvement in Decompensated Patients with Cirrhosis

  • Díaz Ruíz, Raquel|||0000-0002-2259-0289
  • Poca Sans, Maria|||0000-0002-0235-1395
  • Roman, Eva|||0000-0001-9084-8555
  • Panadero, Rocío
  • Cuyàs, Berta|||0000-0001-9988-7163
  • Bañares, Irene
  • Morales, Ángela
  • Puerto, Marta|||0000-0002-1263-9296
  • Lopez-Esteban, Rocio
  • Blazquez, Elena
  • Fernández-Castillo, Marta
  • Correa-Rocha, Rafael|||0000-0003-3456-9986
  • Rapado-Castro, Marta|||0000-0001-8484-6051
  • Breton, Irene|||0000-0003-0263-3728
  • Bañares, Rafael|||0000-0002-0412-8437
  • Soriano, German|||0000-0002-9267-6811
  • García Martínez, Rita|||0000-0003-2159-2757
Background/Objectives: Decompensated cirrhosis is characterized by systemic inflammation and innate and adaptive immune dysfunction. Hepatic encephalopathy (HE) is a prevalent and debilitating condition characterized by cognitive disturbances in which ammonia and inflammation play a synergistic pathogenic role. Extraskeletal functions of vitamin D include immunomodulation, and its deficiency has been implicated in immune dysfunction and different forms of cognitive impairment. The aim was to assess changes in cognitive function and inflammation in decompensated patients with cirrhosis receiving vitamin D supplementation. Methods : Patients with cirrhosis discharged from decompensation in two tertiary hospitals in Spain (from September 2017 to January 2020) were assessed before, at 6 and 12 months after vitamin D supplementation. A comprehensive neuropsychological battery and neuroinflammatory markers were examined. In a subgroup of patients, peripheral immune blood cells were analyzed. Results : Thirty-nine patients were recruited. Of those, 27 completed the 6 months evaluation and were analyzed [age 62.4 ± 11.3 years; 22 men; Model for End-Stage Liver Disease (MELD) 11.7 ± 4.0; prior overt HE 33%; median 25-hydroxyvitamin D (25OHD) plasma level 12.7 µgr/L] and 22 achieved 12 months assessment. At baseline, learning and memory (R = 0.382; p = 0.049) and working memory (R = 0.503; p = 0.047) subtests correlated with plasma 25OHD levels. In addition, processing speed (R = -0.42; p = 0.04), attention (R = -0.48; p = 0.04), Tinnetti balance (R = -0.656; p < 0.001) and Tinnetti score (R = -0.659; p < 0.001) were linked to neuroinflammation marker IL-1β. Patients with lower 25OHD had a greater proportion of TH1cells at baseline and a larger amelioration of IL-1β and IL-6 following supplementation. An improvement in working memory was found after 25OHD replacement (46.7 ± 13 to 50 ± 11; p = 0.047). Conclusions : This study supports that vitamin D supplementation modulates low-grade inflammation in decompensated cirrhosis providing cognitive benefits, particularly in working memory.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Predicting adherence and clinical response of cognitive behavioral therapy among individuals with chronic low back pain plus depressive symptoms, a secondary analysis of a randomized controlled trial

  • Sanabria-Mazo, Juan P.|||0000-0003-1688-435X
  • Royuela-Colomer, Estíbaliz|||0000-0001-9912-9610
  • Navarrete Hidalgo, Jaime|||0000-0002-9482-4822
  • Rodríguez Freire, Carla|||0009-0006-6728-5778
  • Robles, Brenda|||0000-0001-6023-7809
  • McCracken, Lance M.|||0000-0002-9734-0153
  • Feliu-Soler, Albert|||0000-0003-2810-7670
  • Luciano, Juan Vicente|||0000-0003-0750-1599
BACKGROUND: Identifying predictors for adherence and clinical response to psychological therapies is essential for improving individual treatment outcomes. OBJECTIVE: To explore predictors of adherence and clinical response among individuals with co-occurring chronic low back pain (CLBP) and depression receiving cognitive behavioral therapy (CBT). METHODS: This study employs a secondary analysis of data from a randomized controlled trial (NCT04140838), including 156 individuals with CLBP plus depressive symptoms who received CBT. Multiple linear regression analyses were conducted to assess the predictive power of sociodemographic, health status, pain-related, and therapy-related variables on adherence and clinical response. Adherence was measured by therapy progress (number of completed sessions) and therapy completion (attendance at least six out of eight sessions). Clinical response was assessed by a clinically relevant reduction in posttreatment pain interference. RESULTS: Older age, higher therapy credibility, and higher education level predicted greater therapy progress, while higher therapy credibility and lower baseline stress levels predicted greater therapy completion. In addition, higher opioid use, baseline pain interference, and baseline depression levels predicted lower clinical response; in contrast, higher behavioral activation levels, older age, and unemployment predicted higher clinical response. CONCLUSION: Therapy credibility, age, and education level are key predictors of adherence, and baseline levels of pain interference, depression, and behavioral activation are key predictors of clinical response. These findings may inform opportunities to develop more effective personalized therapeutic plans for individuals with CLBP and depression.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Acceptance and commitment therapy in chronic low back pain and comorbid depression, a single-case study with idiographic network analysis

  • Sanabria-Mazo, Juan P.|||0000-0003-1688-435X
  • Rodríguez Freire, Carla|||0009-0006-6728-5778
  • Gallego, Ana|||0000-0002-8060-2495
  • Feliu-Soler, Albert|||0000-0003-2810-7670
  • Suso-Ribera, Carlos|||0000-0002-2655-1017
  • García Palacios, Azucena|||0000-0001-9250-8714
  • Hayes, Steven C.|||0000-0003-4399-6859
  • Hofmann, Stefan G.|||0000-0002-3548-9681
  • Ciarrochi, Joseph|||0000-0003-0471-8100
  • McCracken, Lance M.|||0000-0002-9734-0153
  • Luciano, Juan Vicente|||0000-0003-0750-1599
This study analyzed the efficacy of acceptance and commitment therapy (ACT) in six individuals with chronic low back pain plus depressive symptoms using an idiographic approach within a randomized controlled trial. Daily ecological momentary assessments (EMA) and full assessments at baseline, posttreatment, and follow-up were collected. Outcomes included pain interference, pain intensity, and depressed mood, and the process variable was psychological inflexibility. Analyses involved visual inspection, non-overlap of all pairs, Tau, Tau-U, and idiographic network analysis. Moderate improvements were observed in pain interference (5/6), depressed mood (5/6), and psychological inflexibility (3/6), with limited change in pain intensity (1/6). Most participants (4/6) reported an overall relevant improvement. Idiographic networks showed considerable variability across participants, with psychological inflexibility and depressed mood playing a central role. Findings suggest ACT may help reduce pain interference and depressed mood, highlighting the need for personalized approaches and the continued use of single-case methods combined with EMA.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A Randomized Trial on Hemodynamic Optimization of Cerebral Perfusion after Successful Endovascular Therapy in Patients with Acute Ischemic Stroke (HOPE)

  • Camps-Renom, Pol|||0000-0001-6587-6271
  • Prats Sánchez, Luis Antonio|||0000-0002-3192-4631
  • Ramos-Pachón, Anna|||0000-0002-7136-4245
  • Silva, Y.
  • Giralt Steinhauer, Eva|||0000-0002-7463-0983
  • Flores, A.
  • Ustrell, X.|||0000-0003-3906-8574
  • Moniche, F.
  • Castellanos, M.
  • Aguilera-Simón, Ana|||0000-0003-1428-8212
  • Ezcurra Diaz, Garbiñe|||0000-0002-9511-3117
  • Lambea-Gil, Álvaro|||0000-0003-1785-9201
  • Martí-Fàbregas, Joan|||0000-0001-9229-8649
  • Guasch Jiménez, Marina|||0000-0001-6024-8348
  • Martínez-Domeño, Alejandro|||0000-0002-9933-3192
  • Álvarez-Cienfuegos, J.
  • Fortea-Cabo, G.
  • Morales-Caba, L.
  • Rodriguez Campello, Ana Maria|||0000-0001-8621-1420
  • López-Hernández, N.
  • Corona-García, D.J.
  • Freijo-Guerrero, M.M.
  • Luna, A.
  • Tejada-Meza, H.
  • Marta-Moreno, J.
  • Pardo-Galiana, B.
  • Albert-Lacal, L.
  • Sanz-Monllor, A.
  • Marín-Bueno, Rebeca|||0000-0002-0354-6602
Introduction: In patients with acute ischemic stroke (AIS) secondary to intracranial large vessel occlusion, optimal blood pressure (BP) management following endovascular treatment (EVT) has not yet been established. The randomized trial on Hemodynamic Optimization of Cerebral Perfusion after Successful Endovascular Therapy in Patients with Acute Ischemic Stroke (HOPE) (clinicaltrials.gov id: NCT04892511) aims to demonstrate whether hemodynamic optimization using different systolic BP targets following EVT according to the degree of final recanalization, is more effective than currently recommended BP management in improving functional outcomes of patients with AIS. Methods: HOPE is an investigator-initiated multicenter clinical trial with randomized allocation, open-label treatment, and blinded endpoint evaluation (PROBE). Patients with an anterior circulation AIS within 24 h of symptom onset, treated with EVT, and showing successful recanalization (mTICI ?2b) at the end of the procedure, are equally allocated (1:1) to hemodynamic optimization according to the study protocol versus BP management according to current guidelines (?180/105 mm Hg). The protocol includes two different targets of systolic BP depending on the recanalization status (mTICI = 2b: 140 160 mm Hg; mTICI = 2c/ 3: 100 140 mm Hg). The protocol is applied within the first 72 h and includes BP lowering as well as vasopressor therapies when needed. The primary outcome is the proportion of favorable outcome (modified Rankin Scale [mRS] 0 2) at 90 days. Secondary outcomes include the shift on the mRS score, neurological deterioration, symptomatic intracerebral hemorrhage, and mortality. Conclusion: The HOPE trial will provide new information on the safety and efficacy of different BP targets following EVT according to the degree of final recanalization in patients with AIS.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A narrative review of vascular conduits for coronary artery bypass grafting

  • Iraola-Picornell, Georgina
  • Berastegui García, Elisabet|||0000-0002-1766-2970
  • Castells-Sala, Cristina|||0000-0002-7520-5401
  • Martorell, Jordi|||0000-0002-2043-2762
  • Bayés-Genís, Antoni|||0000-0002-3044-197X
  • Muñoz-Guijosa, Christian|||0000-0002-0272-1704
  • Gálvez-Montón, Carolina|||0000-0003-2254-9371
Coronary artery bypass grafting (CABG) involves creating new conduits to restore blood flow to the heart. Using autologous vascular grafts presents challenges, including infection risk after vein harvesting, and scarcity of viable vein tissue. Researchers are exploring tissue-engineered vascular grafts (TEVGs), aiming to create optimal small-diameter vascular graft (SDVG).
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A pilot study of an online MBCT adaptation to enhance mental health in university students

  • Martínez-Rubio, David|||0000-0002-9346-3869
  • Rodríguez Freire, Carla|||0009-0006-6728-5778
  • Navarrete Hidalgo, Jaime|||0000-0002-9482-4822
  • Colomer Pérez, Natura|||0000-0002-5973-9876
  • Escamilla Robla, Cristina|||0000-0002-7195-2063
  • Solé, Sílvia|||0000-0001-6960-5364
  • Moreno Sigüenza, Yolanda|||0000-0002-1810-7282
  • Montero-Marín, Jesús|||0000-0001-5677-1662
  • Luciano, Juan Vicente|||0000-0003-0750-1599
University students are particularly vulnerable to mental health problems due to factors like stage of the life span and high academic pressure. The current study aimed to assess the feasibility and effectiveness of the online version of the Mindfulness- and Compassion-Based Program (MCBP) for University Life, a promising 6-week instructor-led mindfulness- and compassion-based program tailored for university students. The study followed an uncontrolled design. A total of 21 higher education students (76.2% women; 25 ± 5.68 years old) from the European University of Valencia (Spain) participated in the study. Participants were assessed with self-report measures at baseline, at the end of the 6-week intervention, and at 6-month follow-up. Participants engaged well with the course and formal home practice, attending at least 5 sessions and meditating nearly 4 days per week. There were significant improvements in well-being, psychological distress, insomnia, self-compassion, mindfulness skills, decentering, and self-critical rumination. All those changes remained significant at follow-up except for insomnia levels. Changes in well-being were significantly correlated with changes in self-compassion and decentering. Changes in psychological distress were significantly correlated with changes in self-critical rumination levels. This online intervention could be feasible and effective for enhancing mental health among university students. However, additional robust research with a larger sample size plus a control group is needed to further validate these outcomes. The study was not registered in a clinical trials registry, as it was designed as a pilot feasibility study.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Feasibility of Mindfulness Training for Police Officers at the Spanish National Police Academy

  • Navarrete Hidalgo, Jaime|||0000-0002-9482-4822
  • Garcia-Salvador, Miguel A.
  • Rodríguez Freire, Carla|||0009-0006-6728-5778
  • Feliu-Soler, Albert|||0000-0003-2810-7670
  • Luciano, Juan Vicente|||0000-0003-0750-1599
The aim of this exploratory study was to investigate whether a mindfulness-based intervention (MBI), the 'Mindfulness to Promote Police Well-being' program, was feasible for trainee inspectors of the National Police Academy in Spain. A 7-week MBI was conducted in a group of 61 trainee inspectors (Mage = 43.52, SD = 8.95) from the National Police Academy in Ávila (Spain), divided into two cohorts. Expectancy and opinion, well-being, distress, affect, perceived stress, mindfulness, body awareness and emotion regulation were measured before and after the intervention. Feedback on their at-home meditation practice and assessment of their affect and stress levels were provided weekly too. The intervention was considered logical, satisfactory, recommendable, useful, and non-aversive. Both cohorts were separately analyzed due to remarkable contextual differences in the implementation of the MBI. Paired-samples t-tests showed that the first cohort significantly improved their mental well-being, trait mindfulness, body awareness, general distress, and difficulties in emotion regulation, with medium-to-large effect sizes. Correlation analyses showed that changes in both mental well-being and general distress were significantly associated with changes in trait mindfulness, body awareness, and difficulties in emotion regulation. Linear mixed model analysis showed that participants of the first cohort improved week-by-week their perceived stress and positive affect levels. Overall, the second cohort remained unchanged. Considering the above, a feasible way to promote mindfulness in policing might be through the police training system infrastructure. Police officers may find mindfulness training acceptable and appropriate in this context.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Efficacy of low-dose Naltrexone in women with fibromyalgia syndrome, a 12-month randomised, double-blind, placebo-controlled single-centre clinical trial (INNOVA Study)

  • Rodríguez Freire, Carla|||0009-0006-6728-5778
  • Navarrete Hidalgo, Jaime|||0000-0002-9482-4822
  • Rozadilla-Sacanell, Antoni|||0000-0002-7555-189X
  • Sanabria-Mazo, Juan P.|||0000-0003-1688-435X
  • Pino Gaya, Beatriz del
  • Borràs, Xavier|||0000-0003-3972-1385
  • Feliu-Soler, Albert|||0000-0003-2810-7670
  • Luciano, Juan Vicente|||0000-0003-0750-1599
BACKGROUND: Low-dose naltrexone (LDN) has been used off-label for fibromyalgia syndrome (FMS) for over a decade, supported by small crossover trials. The INNOVA study evaluated the safety and efficacy of LDN 4.5 mg versus placebo on pain intensity over 12 months in women with FMS. METHODS: In total, 98 women with FMS were randomised to LDN 4.5 mg/day (n = 48) or placebo (n = 50). The primary outcome was change in pain intensity (NRS 0-10) from baseline to 3 months in the intention-to-treat population. Secondary outcomes included functional impairment (FIQR), anxiety-depressive symptoms (DASS-21), cognitive impairment (MISCI), disability (WHODAS 2.0), pathological worry (GAD-7) and impression of change (PGIC/PSIC), assessed at baseline and at 3, 6 and 12 months. Perceived treatment allocation and safety were also assessed. RESULTS: At 3 months, mean change in pain intensity was -0.33 points with LDN and -0.64 with placebo, with an adjusted between-group difference of 0.49 (p = 0.236, d = 0.19). Secondary outcomes showed minor and inconsistent changes, with low and similar responder rates (p = 0.219-0.954). Exploratory analyses suggested some improvement among participants who believed they had received LDN, although effects were inconsistent. Adverse events, predominantly mild and transient, were reported by 33 (68.8%) participants in LDN and 36 (72%) in placebo, and no treatment-related serious events occurred. CONCLUSIONS: LDN was well tolerated but did not demonstrate a clinically meaningful benefit over placebo for pain-related outcomes, underscoring the need for more effective pharmacological treatments. SIGNIFICANCE STATEMENT: This RCT provides the first long-term evidence on the efficacy and safety of LDN in FMS. LDN (4.5 mg), administered as an add-on treatment, has a favourable safety profile, but the findings indicate that it does not produce clinically meaningful improvements in FMS symptoms compared to placebo at short- or long-term follow-up. These findings contribute to the growing body of evidence questioning its clinical utility.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

The silence of opioids-dependent chronic pain patients: A text mining analysis from sex and gender perspective

  • Carratalá, Claudia
  • Agulló, Laura
  • Serrano-Gadea, Noelia
  • Escorial, Mónica
  • López-Mañogil, Elena
  • Bernardes, Sonia F.
  • Peiró, Ana M.
  • Carracedo-Garnateo, Patricia|||0000-0002-9352-9565
  • Miró Martínez, Pau|||0000-0001-9573-9104
[EN] Existing evidence indicates sex-related differences in Prescription Opioid Use Disorder (OUD) in Chronic Non-Cancer Pain (CNCP). However to date, there is scant evidence for other socioeconomic factors in these differences. Our aim was to enquire about the influence of gender and drug copayment of OUD narratives by the text mining analysis. A prospective mixed-methods study was designed and performed at Pain Unit (PU) including 238 real world patients with CNCP divided in controls (n = 206) and OUD cases (n = 32) due to DSM-5 diagnosis Variables related to pain, sleep, mental and health status were collected in together with sex and gender interaction, in pain status, along 30-45 min face-to-face interviews. Sex differences were observed due to women's significantly older ages, with a stronger impact on mental health, and an even stronger one for the OUD women. Globally, OUD cases were more unemployed vs the CNCP controls, and on a significantly higher median opioid daily dose of 90 [100] mg/day. Although OUD participants did more social activities, they tended to use less vocabulary to express themselves regardless of their sex, gender role or economic status. In contrast, the CNCP participants presented more differences driven by their incomes, with "limited" being the most discriminating word for those on low income, followed by "less" and "help". Here, the most significant word of CNCP women was "husband", followed by "tasks". In contrast, gender reproductive roles shared similarities in both sexes, being one of the most discriminatory words "help". The data show that OUD patients seem to have a marked influence of OUD on poorer lexicon and simpler narrative, together with a significant impact of socioeconomic factors on the CNCP narratives. The conclusion suggests to extend the research to better understand the effect of sex, gender and socioeconomic status in CNCP especially on OUD women's health., This work was funded by the Carlos III Health Institute (ISCIII, Madrid, Spain) with a grant to the Independent Clinical Research Projects of the Strategic Action in Health 2017-2020 (AES, ICI20/00146); Scholarships for Research Stay (ISABIAL, Alicante, 2022) and Senior Grants (Official College of Physicians of the Province of Alicante, COMA, 2002). This work received a 2022 Communication Award during the VXIII National Spanish Pain Society Congress Valencia, Spain); the MORPHEO 2024-01 National Drug Plan Budget from Spanish Ministry of Health (Spain, 2024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Gendered dimension of chronic pain patients with low and middle income: A text mining analysis

  • Peiró, Ana M.
  • Agulló, Laura
  • Bernardes, Sonia F.
  • Carracedo-Garnateo, Patricia|||0000-0002-9352-9565
[EN] Inferences about gender differences and socioeconomic status in Chronic Non-Cancer Pain (CNCP) management may shape health care. This can be a particularly relevant issue for women, who continue to more often assume reproductive gender roles. The objective of this study was to explore the gendered impact of CNCP on low-and middle-income women and men through text mining analysis.Methods This is a mixed-method study using individual interviews (duration between 40-60 minutes) of 181 CNCP patients (71% females) in a tertiary Pain Care Unit, and applying the text mining methodology. Incomes (low or middle) and gender roles (productive vs. reproductive)".Results Gender differences were identified in the words used to describe pain impact in working and social life, domestic responsibilities, and family relationships. Albeit having similar CNCP severity and interference, women were on average 8 years older, compared to men, with longer referral time from Primary Care, less retired but more homemakers, showing a greater impact on their mental health. The most discriminating word explaining pain impact for CNCP women was "husband", for men was "work", especially among middle income groups. The way men, with a productive gender role, talked about the impact of CNCP in their lives stressed the word "work". In contrast, men with reproductive roles stressed the words "chores, family or limited" as women with low-income did. Only low-income men used the word "help". The text mining analysis indicates a discrepant distribution of men and women into traditional gender social roles that are consistent with stereotypical traits and may have an impact on pain care. There is a need of an intersectional perspective as part of pain assessment, to develop novel self-management interventions for men and women., This work was funded by The Carlos III Health Institute (ISCIII, Madrid, Spain) through a grant to Independent Clinical Research Projects of the Strategic Action in Health 2017-2020 (AES, ICI20/00146). Scholarships for Research Stay (ISABIAL, Alicante, 2022) and Senior Grants (Official College of Physicians of the Province of Alicante, COMA, 2002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
DAU Arxiu Digital de la Universitat Ramon Llull
Publication Artículo científico (JournalArticle)

A narrative review of vascular conduits for coronary artery bypass grafting

  • Iraola, Georgina
  • Berastegui, Elisabet
  • Castells-Sala, Cristina
  • Martorell, Jordi
  • Bayes-Genis, Antoni
  • Muñoz-Guijosa, Christian
  • Gálvez-Montón, Carolina
Coronary artery bypass grafting (CABG) involves creating new conduits to restore blood flow to the heart. Using autologous vascular grafts presents challenges, including infection risk after vein harvesting, and scarcity of viable vein tissue. Researchers are exploring tissue-engineered vascular grafts (TEVGs), aiming to create optimal small-diameter vascular graft (SDVG) (<6 mm) for CABG surgery. TEVGs with suitable long-term patency could offer a promising alternative, potentially reduce patient morbidity and improve surgical outcomes. However, no SDVG is commercially available for CABG surgery in Europe, and no new clinical trials of coronary TEVGs have been reported since 2018. This narrative review summarizes the development and use of SDVG (<6 mm) for CABG, focusing on TEVGs and cell-seeding strategies. We outline the main types of grafts tested in preclinical and early clinical studies and highlight how different cell sources and seeding approaches aim to enhance graft functionality, patency, and long-term outcome., info:eu-repo/semantics/publishedVersion
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Assessment of Human SARS CoV-2-Specific T-Cell Responses Elicited In Vitro by New Computationally Designed mRNA Immunogens (COVARNA)

  • Esteban, Ignasi
  • Pastor-Quiñones, Carmen
  • Usero, Lorena
  • Aurrecoechea, Elena
  • Franceschini, Lorenzo
  • Esprit, Arthur
  • Gelpí, Josep Lluís
  • Martínez-Jiménez, Francisco
  • López-Bigas, Núria
  • Breckpot, Karine
  • Thielemans, Kris
  • Leal, Lorna
  • Gómez, Carmen Elena
  • Sisteré-Oró, Marta
  • Meyerhans, Andreas
  • Esteban, Mariano
  • Alonso, María José
  • García, Felipe
  • Plana, Montserrat
The COVID-19 pandemic has brought significant changes and advances in the field of vaccination, including the implementation and widespread use of encapsidated mRNA vaccines in general healthcare practice. Here, we present two new mRNAs expressing antigenic parts of the SARS-CoV-2 spike protein and provide data supporting their functionality. The first mRNA, called RBD-mRNA, encodes a trimeric form of the virus spike protein receptor binding domain (RBD). The other mRNA, termed T-mRNA, codes for the relevant HLA I and II spike epitopes. The two mRNAs (COVARNA mRNAs) were designed to be used for delivery to cells in combination, with the RBD-mRNA being the primary source of antigen and the T-mRNA working as an enhancer of immunogenicity by supporting CD4 and CD8 T-cell activation. This innovative approach substantially differs from other available mRNA vaccines, which are largely directed to antibody production by the entire spike protein. In this study, we first show that both mRNAs are functionally transfected into human antigen-presenting cells (APCs). We obtained peripheral blood mononuclear cell (PBMC) samples from three groups of voluntary donors differing in their immunity against SARS-CoV-2: non-infected (naïve), infected-recovered (convalescent), and vaccinated. Using an established method of co-culturing autologous human dendritic cells (hDCs) with T-cells, we detected proliferation and cytokine secretion, thus demonstrating the ability of the COVARNA mRNAs to activate T-cells in an antigen-specific way. Interestingly, important differences in the intensity of the response between the infected-recovered (convalescent) and vaccinated donors were observed, with the levels of T-cell proliferation and cytokine secretion (IFNγ, IL-2R, and IL-13) being higher in the vaccinated group. In summary, our data support the further study of these mRNAs as a combined approach for future use as a vaccine., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The Combination of an mRNA Immunogen, a TLR7 Agonist and a PD1 Blocking Agent Enhances In-Vitro HIV T-Cell Immune Responses

  • Usero, Lorena
  • Leal, Lorna
  • Gómez, Carmen Elena
  • Miralles, Laia
  • Aurrecoechea, Elena
  • Esteban, Ignasi
  • Torres, Berta
  • Inciarte, Alexy
  • Perdiguero, Beatriz
  • Esteban, Mariano
  • García, Felipe
  • Plana, Montserrat
The development of new strategies to achieve a functional cure for HIV remains a priority. We tested a novel HIV therapeutic vaccine using unmodified mRNA (TMEP-B) and mRNA modified by 1-methyl-3'-pseudouridylyl (TMEP-Bmod) expressing both a multiepitopic sequences from Gag, Pol, and Nef proteins, including different CD4 and CD8 T-cell epitopes functionally associated with HIV control in transfected monocyte-derived dendritic cells (MDDCs) obtained from HIV infected patients. In vitro assays were used to test the mRNAs alone and in combination with immunomodulator agents, such as the TLR-7 agonist Vesatolimod and the PD-1 antagonist Nivolumab to try to improve HIV-specific cellular immune responses. Combining the mRNAs with the immunomodulators enhanced HIV-specific T-cell responses, together with the secretion of IFNγ, IP10, MIP-1α, and MIP-1β, which are fundamental mediators of viral control. Our data suggest that the mRNA vaccine prototypes TMEP-B and TMEP-Bmod, when combined with Vesatolimod and/or Nivolumab, could achieve functional cure for patients with HIV., This study was partially supported by grants from the Spanish Ministry of Economy (MINECO) (grants: SAF-2017-88089-R and RTI2018-096309-B-I00); the Fondo Europeo para el Desarrollo Regional (FEDER); the SPANISH AIDS Research Network RD16/0025/0002 and RD16/0025/0014- ISCIII-FEDER (RIS); Projects FIS PI18/00699, COV20/00214 and ICI20/00067 financed by the Instituto de Salud Carlos III (ISCIII) and co-financed by the European Union; HIVACAT program; the CERCA Programme/Generalitat de Catalunya SGR 615 and SGR 653; and by the European Commission (grant numbers: FP7-HEALTH-2013-INNOVATION-1 602570-2 and H2020-SC1-2016-2017 (H2020-SC1-2016- RTD) Proposal: 731626-HIVACAR)., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Psychometric properties of the engaged living scale (ELS) Spanish version in a large sample of Spanish pilgrims

  • Navarrete, J.
  • Colomer-Carbonell, A.
  • Sanabria-Mazo, J. P.
  • Luciano, J. V.
  • Soler, J.
  • García-Campayo, J.
  • Demarzo, M.
  • Montero-Marín, J.
  • Bohlmeijer, E. T.
  • Campos, D.
  • Cebolla, A.
  • Feliu-Soler, A.
Engaged Living (values clarity and committed action) is a main process of psychological flexibility as defined by Acceptance and Commitment Therapy. The Engaged Living Scale (ELS) was designed to measure it. The purpose of this study was to translate the ELS to Spanish and to examine the reliability and validity of its scores in a heterogeneous sample of 752 Spanish pilgrims of the Way of Saint James (pre-post analysis: n = 285). Confirmatory factor analyses were computed to study the structural validity of the ELS scores. In addition, network analyses were computed to examine convergent and discriminant validity. The included variables were engaged living, mindfulness facets, satisfaction with life, subjective happiness, affect, depression, anxiety, and perceived stress. Results showed that the Spanish version of the ELS is two-factorial (valued living [VL] and life fulfillment [LF]). The ELS scores showed good reliability. In addition, it was able to detect VL and LF changes after the Way underscoring its sensitivity to change. The network analyses indicated adequate convergent and discriminant validity of the ELS. Changes in satisfaction with life, life fulfillment, happiness, and valued living scores were most strongly associated with changes in perceived stress, affect, mindfulness facets, depression, and anxiety. In short, the Spanish version of the ELS appeared to be a reliable and valid instrument to assess the engaged response style in the current samples.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Applying a School-Based Mindfulness and Compassion Program (“Escuelas Despiertas”) in Spanish Secondary Schools to Reduce Psychological Distress in Adolescents: A Randomized Controlled Trial

  • Aguilera, Pilar
  • Navarro-Gil, Mayte
  • Pérez-Aranda, Adrián
  • Armas-Landaeta, Carilene
  • Beltrán-Ruiz, María
  • Rodríguez-Freire, Carla
  • Camarero-Grados, Loreto
  • García-Campayo, Javier
  • Montero-Marín, Jesús
Adolescents present high risk of developing mental health problems. Different school-based programs have been designed to prevent and treat the psychological distress that they often experience with disparate results. In this study, we tested the efficacy of a school-based program framed into the “Escuelas Despiertas” initiative that teaches adolescents mindfulness and compassion to improve their mental health. In this randomized controlled trial, high school students from four Spanish secondary education centers (N = 277) were randomly assigned to a school-based 10-session mindfulness and compassion program (“Escuelas Despiertas”) or a relaxation program. Participants were assessed at baseline, posttreatment, and at 6-month follow-up. The main outcome was psychological distress (General Health Questionnaire, GHQ-12). Classroom climate and relaxation habits, among others, were assessed as secondary outcomes. Students who underwent the “Escuelas Despiertas” program experienced small within group improvements posttreatment in GHQ-12 scores (p = 0.001, d = 0.31) and in relaxation habits (p = 0.001, d = 0.35), although these were not significant compared to the control group. Classroom climate presented a small deterioration in the “Escuelas Despiertas” group compared to the relaxation group in the follow-up assessment, but this effect was not statistically significant after correcting for multiple comparisons. In conclusion, the “Escuelas Despiertas” program produced small short-term improvements in psychological distress and relaxation habits in adolescents which were not significant compared to a relaxation intervention. In line with previous studies, it seems that punctual interventions delivered during some weeks might not be the best approach for adolescents, for whom mindfulness- and-compassion-based programs may not be engaging enough for different reasons.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Personalized Blood Pressure Targeting After Endovascular Therapy for Acute Ischemic Stroke

  • Camps-Renom, Pol
  • Guasch-Jiménez, Marina
  • Álvarez-Cienfuegos, Juan
  • López-Hernández, Nicolás
  • Rodríguez-Campello, Ana
  • Tejada-Meza, Herbert
  • et al
Importance Optimal blood pressure (BP) management after successful endovascular therapy for acute ischemic stroke remains uncertain, as intensive lowering has shown no benefit or potential harm in prior trials. Objective To determine whether a reperfusion-guided systolic BP control strategy improves functional outcomes compared with guideline-recommended management after successful endovascular therapy for acute ischemic stroke. Design, Setting, and Participants This investigator-initiated, multicenter, prospective, randomized, open-label clinical trial with blinded end point assessment was conducted among adults with acute ischemic stroke due to anterior circulation large-vessel occlusion who achieved successful reperfusion (modified Thrombolysis in Cerebral Infarction [mTICI] score ≥2b) after endovascular therapy at 11 comprehensive stroke centers in Spain between June 14, 2021, and October 1, 2025, with 90-day follow-up. Data analysis was conducted from February 1 to March 12, 2026. Interventions Participants were randomly assigned (1:1) to a reperfusion-guided systolic BP strategy (140-160 mm Hg for mTICI score of 2b; 100-140 mm Hg for mTICI score of 2c/3) or guideline-recommended management (systolic BP <180 mm Hg) for 72 hours using antihypertensive agents or vasopressors as needed. Main Outcomes and Measures The primary outcome was a favorable functional outcome, defined as a modified Rankin Scale score of 0 to 2 at 90 days, assessed in the intention-to-treat population. Of 446 enrolled patients, 440 were included in the intention-to-treat analysis (mean age, 75 years; 53% women); 6 were excluded due to withdrawal or consent withdrawal. Results Among 440 patients (mean [SD] age, 75 [12] years; 233 [53.0%] women), 215 were assigned to the intervention group and 225 to the control group. At 90 days, 129 patients (60.0%) in the intervention group and 106 (47.1%) in the control group achieved a favorable functional outcome (absolute risk difference, 13.3%; 95% CI, 4.1%-22.6%; P = .005). Hemorrhagic transformation occurred in 48 patients (22.3%) in the intervention group and 71 (31.6%) in the control group (odds ratio, 0.62; 95% CI, 0.41-0.95). The rates of symptomatic intracranial hemorrhage (3.5% vs 3.9%) and 90-day mortality (15.4% vs 15.6%) did not differ between groups. Serious adverse events occurred in 34 patients (15.8%) in the intervention group and 27 (12.0%) in the control group. Conclusions and Relevance In this randomized clinical trial, a reperfusion-guided BP strategy improved functional outcomes and reduced hemorrhagic transformation without increasing major safety events, supporting a tailored approach to postthrombectomy BP management.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

A Randomized Trial on Hemodynamic Optimization of Cerebral Perfusion after Successful Endovascular Therapy in Patients with Acute Ischemic Stroke (HOPE)

  • Camps-Renom, Pol
  • Guasch-Jiménez, Marina
  • Martínez-Domeño, Alejandro
  • Prats-Sánchez, Luis
  • Ramos-Pachón, Anna
  • Álvarez-Cienfuegos, Juan
  • Silva, Yolanda
  • Fortea-Cabo, Gerardo
  • Morales-Caba, Luis
  • Rodríguez-Campello, Ana
  • Giralt-Steinhauer, Eva
  • Flores, Alan
  • Ustrell, Xavier
  • López-Hernández, Nicolás
  • Corona-García, Diego José
  • Freijo-Guerrero, Mari Mar
  • Luna, Alain
  • Tejada-Meza, Herbert
  • Marta-Moreno, Javier
  • Moniche, Francisco
  • Pardo-Galiana, Blanca
  • Castellanos, Mar
  • Albert-Lacal, Laura
  • Sanz-Monllor, Ainara
  • Aguilera-Simón, Ana
  • Marín, Rebeca
  • Ezcurra-Díaz, Garbiñe
  • Lambea-Gil, Álvaro
  • Martí-Fàbregas, Joan
Introduction: In patients with acute ischemic stroke (AIS) secondary to intracranial large vessel occlusion, optimal blood pressure (BP) management following endovascular treatment (EVT) has not yet been established. The randomized trial on Hemodynamic Optimization of Cerebral Perfusion after Successful Endovascular Therapy in Patients with Acute Ischemic Stroke (HOPE) (clinicaltrials.gov id: NCT04892511) aims to demonstrate whether hemodynamic optimization using different systolic BP targets following EVT according to the degree of final recanalization, is more effective than currently recommended BP management in improving functional outcomes of patients with AIS. Methods: HOPE is an investigator-initiated multicenter clinical trial with randomized allocation, open-label treatment, and blinded endpoint evaluation (PROBE). Patients with an anterior circulation AIS within 24 h of symptom onset, treated with EVT, and showing successful recanalization (mTICI ≥2b) at the end of the procedure, are equally allocated (1:1) to hemodynamic optimization according to the study protocol versus BP management according to current guidelines (≤180/105 mm Hg). The protocol includes two different targets of systolic BP depending on the recanalization status (mTICI = 2b: 140–160 mm Hg; mTICI = 2c/3: 100–140 mm Hg). The protocol is applied within the first 72 h and includes BP lowering as well as vasopressor therapies when needed. The primary outcome is the proportion of favorable outcome (modified Rankin Scale [mRS] 0–2) at 90 days. Secondary outcomes include the shift on the mRS score, neurological deterioration, symptomatic intracerebral hemorrhage, and mortality. Conclusion: The HOPE trial will provide new information on the safety and efficacy of different BP targets following EVT according to the degree of final recanalization in patients with AIS.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Transcriptomic Analysis Reveals That Retinal Neuromodulation Is a Relevant Mechanism in the Neuroprotective Effect of Sitagliptin in an Experimental Model of Diabetic Retinopathy

  • Ramos Abellan, Hugo
  • Bogdanov Baruj, Patricia
  • Deàs Just, Anna
  • Hernández Buñuel, Cristina
  • Simó Canonge, Rafael
Diabetic retinopathy; Sitagliptin; Synaptic signal transmission, Retinopatia diabètica; Sitagliptina; Transmissió del senyal sinàptic, Retinopatía diabética; Sitagliptina; Transmisión de señal sináptica, Synaptic dysfunction and neuronal damage have been extensively associated with diabetic retinopathy (DR). Our group evidenced that chronic hyperglycemia reduces the retinal expression of presynaptic proteins, which are crucial for proper synaptic function. The aim of the study was to explore the effect of topically administered sitagliptin, an inhibitor of the enzyme dipeptidyl peptidase-4, on the retinal expression patterns of an experimental model of DR. Transcriptome analysis was performed, comparing the retinas of 10 diabetic (db/db) mice randomly treated with sitagliptin eye drops (10 mg/mL) twice daily and the retinas of 10 additional db/db mice that received vehicle eye drops. Ten non-diabetic mice (db/+) were used as a control group. The Gene Ontology (GO) and Reactome databases were used to perform the gene set enrichment analysis (GSEA) in order to explore the most enriched biological pathways among the groups. The most differentiated genes of these pathways were validated through quantitative RT-PCR. Transcriptome analysis revealed that sitagliptin eye drops have a significant effect on retinal expression patterns and that neurotransmission is the most enriched biological process. Our study evidenced enriched pathways that contain genes involved in membrane trafficking, transmission across chemical synapses, vesicle-mediated transport, neurotransmitter receptors and postsynaptic signal transmission with negative regulation of signaling as a consequence of neuroprotector treatment with sitagliptin. This improves the modulation of the macromolecule biosynthetic process with positive regulation of cell communication, which provides beneficial effects for the neuronal metabolism. This study suggests that topical administration of sitagliptin ameliorates the abnormalities on presynaptic and postsynaptic signal transmission during experimental DR and that this improvement is one of the main mechanisms behind the previously demonstrated beneficial effects., This research was funded by grants from the Ministerio de Economía y Competitividad (PID2019-104225RB-I00) and the Instituto de Salud Carlos III (DTS18/0163, PI19/01215 and ICI20/00129). The study funder was not involved in the design of the study.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Local administration of porcine immunomodulatory, chemotactic and angiogenic extracellular vesicles using engineered cardiac scaffolds for myocardial infarction

  • Moron-Font, Miriam
  • Clos-Sansalvador, Marta
  • Calle, Alexandra
  • Morancho Retana, Anna
  • Rosell Novel, Anna
  • Monguió-Tortajada, Marta
  • Prat-Vidal, Cristina
  • Gastelurrutia, Paloma
Ingeniería de tejido cardíaco; Exosomas; Infiltración, Enginyeria de teixits cardíacs; Exosomes; Infiltració, Cardiac tissue engineering; Exosomes; Infiltration, The administration of extracellular vesicles (EV) from mesenchymal stromal cells (MSC) is a promising cell-free nanotherapy for tissue repair after myocardial infarction (MI). However, the optimal EV delivery strategy remains undetermined. Here, we designed a novel MSC-EV delivery, using 3D scaffolds engineered from decellularised cardiac tissue as a cell-free product for cardiac repair. EV from porcine cardiac adipose tissue-derived MSC (cATMSC) were purified by size exclusion chromatography (SEC), functionally analysed and loaded to scaffolds. cATMSC-EV markedly reduced polyclonal proliferation and pro-inflammatory cytokines production (IFNγ, TNFα, IL12p40) of allogeneic PBMC. Moreover, cATMSC-EV recruited outgrowth endothelial cells (OEC) and allogeneic MSC, and promoted angiogenesis. Fluorescently labelled cATMSC-EV were mixed with peptide hydrogel, and were successfully retained in decellularised scaffolds. Then, cATMSC-EV-embedded pericardial scaffolds were administered in vivo over the ischemic myocardium in a pig model of MI. Six days from implantation, the engineered scaffold efficiently integrated into the post-infarcted myocardium. cATMSC-EV were detected within the construct and MI core, and promoted an increase in vascular density and reduction in macrophage and T cell infiltration within the damaged myocardium. The confined administration of multifunctional MSC-EV within an engineered pericardial scaffold ensures local EV dosage and release, and generates a vascularised bioactive niche for cell recruitment, engraftment and modulation of short-term post-ischemic inflammation., This work was supported in part by grants from Fundació la Marató de TV3 (201516-10, 201502-30), the PERIS (SLT002/16/00234) and SGR programmes (2017-SGR-301 REMAR Group, 2017-SGR-1427 and 2017-SGR-483 ICREC Group) from the Generalitat de Catalunya, the Spanish Ministry of Economy and Competitiveness-MICINN (SAF2017-84324-C2-1-R; PID2019-110137RB-I00; PID2019-107145RB-I00), Instituto de Salud Carlos III (PI17/01487, PIC18/00014, ICI19/00039, PI18/00256, PI18/01227, and ICI20/00135), ISCIII-REDinREN (RD16/0009 Feder Funds), Red de Terapia Celular-TerCel (RD16/0011/0006), CIBER Cardiovascular (CB16/11/00403) projects as a part of the Plan Nacional de I + D + I, and it was co-funded by ISCIII-Subdirección General de Evaluación y el Fondo Europeo de Desarrollo Regional (FEDER), AGAUR (2019PROD00122), Sociedad Española de Cardiología, Societat Catalana de Cardiologia, PCMR[C] and EoI Collaborative Projects on Regenerative Medicine 2019, and Institut Català de Salut (ICS). PG is sponsored by the PERIS (SLT002/16/00209) from the Generalitat de Catalunya. AR is supported by the Miguel Servet program (CPII15/00003) and research grants (PI16/00981) from the Instituto de Salud Carlos III, and co-financed by the European Regional Development Fund. FEB is a researcher from Fundació Institut de Recerca en Ciències de la Salut Germans Trias i Pujol, supported by the Health Department of the Catalan Government (Generalitat de Catalunya).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

A narrative review of vascular conduits for coronary artery bypass grafting

  • Iraola, Georgina
  • Berastegui, Elisabet
  • Castells-Sala, Cristina
  • Martorell, Jordi
  • Bayes-Genis, Antoni
  • Muñoz-Guijosa, Christian
  • Gálvez-Montón, Carolina
Coronary artery bypass grafting (CABG) involves creating new conduits to restore blood flow to the heart. Using autologous vascular grafts presents challenges, including infection risk after vein harvesting, and scarcity of viable vein tissue. Researchers are exploring tissue-engineered vascular grafts (TEVGs), aiming to create optimal small-diameter vascular graft (SDVG) (<6 mm) for CABG surgery. TEVGs with suitable long-term patency could offer a promising alternative, potentially reduce patient morbidity and improve surgical outcomes. However, no SDVG is commercially available for CABG surgery in Europe, and no new clinical trials of coronary TEVGs have been reported since 2018. This narrative review summarizes the development and use of SDVG (<6 mm) for CABG, focusing on TEVGs and cell-seeding strategies. We outline the main types of grafts tested in preclinical and early clinical studies and highlight how different cell sources and seeding approaches aim to enhance graft functionality, patency, and long-term outcome., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Ocular and Plasma Pharmacokinetics of Sitagliptin Eye Drops: Preclinical Data

  • Létondor, Anne
  • Ramos Abellán, Hugo
  • Simó Canonge, Rafael
  • Hernandez, Cristina
Eye drops; Pharmacokinetics; Sitagliptin, Gotas oftálmicas; Farmacocinética; Sitagliptina, Gotes oftàlmiques; Farmacocinètica; Sitagliptina, Background/Objectives: Early stages of diabetic retinopathy are currently considered an unmet medical need due to the lack of effective treatments beyond proper monitoring and control of glycemia and blood pressure. Sitagliptin eye drops have emerged as a new therapeutic approach against early stages of the disease, as they can prevent its main hallmarks, including both neurodegeneration and microvascular impairment. Interestingly, all of these effects occur without any glycemic systemic improvement. In the present study, we aimed to investigate the pharmacokinetics and distribution of the drug within the eye and plasma. Methods: A total of 48 male New Zealand rabbits were treated with topical administration (eye drops) of sitagliptin at two concentrations: 5 mg/mL and 10 mg/mL. Blood, iris/ciliary body, retina/choroid, aqueous humor, and vitreous humor samples were collected at specific intervals post-administration (10 and 30 min and 1, 3, 6, 15, and 24 h), processed, and analyzed using an LC-MS/MS method. The pharmacokinetics of sitagliptin were then calculated, and statistical comparisons were performed. Results: Our findings indicate that sitagliptin reaches the retina prior to the aqueous and vitreous humors, suggesting that its absorption follows the transscleral route. Additionally, systemic absorption was minimal and below pharmacologically active concentrations. Conclusions: These results support the use of an eye drop formulation for the treatment of diabetic retinopathy and other retinal diseases., This research was funded by a grant from the Instituto de Salud Carlos III (ICI20/00129).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Neuromodulation Induced by Sitagliptin: A New Strategy for Treating Diabetic Retinopathy

  • Ramos Abellan, Hugo
  • Bogdanov Baruj, Patricia
  • Huerta Alonso, Jordi
  • Valeri Sala, Marta
  • Hernández Pascual, Cristina
  • Simó Canonge, Rafael
  • Sabater Martínez, David
Presynaptic proteins; Retinal neurodegeneration; Sitagliptin, Proteínas presinápticas; Neurodegeneración retiniana; Sitagliptina, Proteïnes presinàptiques; Neurodegeneració retiniana; Sitagliptina, Diabetic retinopathy (DR) involves progressive neurovascular degeneration of the retina. Reduction in synaptic protein expression has been observed in retinas from several diabetic animal models and human retinas. We previously reported that the topical administration (eye drops) of sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, prevented retinal neurodegeneration induced by diabetes in db/db mice. The aim of the present study is to examine whether the modulation of presynaptic proteins is a mechanism involved in the neuroprotective effect of sitagliptin. For this purpose, 12 db/db mice, aged 12 weeks, received a topical administration of sitagliptin (5 μL; concentration: 10 mg/mL) twice per day for 2 weeks, while other 12 db/db mice were treated with vehicle (5 μL). Twelve non-diabetic mice (db/+) were used as a control group. Protein levels were assessed by western blot and immunohistochemistry (IHC), and mRNA levels were evaluated by reverse transcription polymerase chain reaction (RT-PCR). Our results revealed a downregulation (protein and mRNA levels) of several presynaptic proteins such as synapsin I (Syn1), synaptophysin (Syp), synaptotagmin (Syt1), syntaxin 1A (Stx1a), vesicle-associated membrane protein 2 (Vamp2), and synaptosomal-associated protein of 25 kDa (Snap25) in diabetic mice treated with vehicle in comparison with non-diabetic mice. These proteins are involved in vesicle biogenesis, mobilization and docking, membrane fusion and recycling, and synaptic neurotransmission. Sitagliptin was able to significantly prevent the downregulation of all these proteins. We conclude that sitagliptin exerts beneficial effects in the retinas of db/db mice by preventing the downregulation of crucial presynaptic proteins. These neuroprotective effects open a new avenue for treating DR as well other retinal diseases in which neurodegeneration/synaptic abnormalities play a relevant role., This research was funded by grants from the Ministerio de Economía y Competitividad (PID2019-104225RB-I00) and the Instituto de Salud Carlos III (DTS18/0163, PI19/01215, and ICI20/00129). The study funder was not involved in the design of the study.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Minimum Effective Dose of DPP-4 Inhibitors for Treating Early Stages of Diabetic Retinopathy in an Experimental Model

  • Bogdanov Baruj, Patricia
  • Ramos Abellan, Hugo
  • Valeri Sala, Marta
  • Deàs Just, Anna
  • Huerta Alonso, Jordi
  • Hernández Pascual, Cristina
  • Simó Canonge, Rafael
Dipeptidyl peptidase-4 inhibitors; Experimental diabetes; Retinal neurodegeneration, Inhibidores de la dipeptidil peptidasa-4; Diabetes experimental; Neurodegeneración retiniana, Inhibidors de la dipeptidil peptidasa-4; Diabetis experimental; Neurodegeneració de la retina, The neurovascular unit (NVU) plays an essential role in the development of diabetic retinopathy (DR). We previously reported that the topical administration (eye drops) of sitagliptin and saxagliptin, two dipeptidyl peptidase-4 inhibitors (DPP-4i), prevents retinal neurodegeneration and vascular leakage in db/db mice. The aim of the present study is to evaluate the minimum effective dose of the topical administration of these DPP-4i. For this purpose, sitagliptin and saxagliptin were tested at different concentrations (sitagliptin: 1 mg/mL, 5 and 10 mg/mL, twice per day; saxagliptin: 1 and 10 mg/mL, once or twice per day) in db/db mice. As end points of efficacy, the hallmarks of NVU impairment were evaluated: reactive gliosis, neural apoptosis, and vascular leakage. These parameters were assessed by immunohistochemistry, cell counting, and the Evans blue method, respectively. Our results demonstrated that the minimum effective dose is 5 mg/mL twice per day for sitagliptin, and 10 mg/mL twice per day for saxagliptin. In conclusion, this study provides useful results for the design of future preclinical regulatory studies and for planning clinical trials., This research was funded by grants from the Ministerio de Economía y Competitividad (PID2019-104225RB-I00) and the Instituto de Salud Carlos III (DTS18/0163, PI19/01215 and ICI20/00129). The study funder was not involved in the design of the study.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Neurovascular Unit: A New Target for Treating Early Stages of Diabetic Retinopathy

  • Simó Servat, Olga
  • Bogdanov Baruj, Patricia
  • Hernández Pascual, Cristina
  • Simó Canonge, Rafael
Retinopatía diabética; Neurodegeneración; Unidad neurovascular, Retinopatia diabètica; Neurodegeneració; Unitat neurovascular, Diabetic retinopathy; Neurodegeneration; Neurovascular unit, The concept of diabetic retinopathy as a microvascular disease has evolved and is now considered a more complex diabetic complication in which neurovascular unit impairment plays an essential role and, therefore, can be considered as a main therapeutic target in the early stages of the disease. However, neurodegeneration is not always the apparent primary event in the natural story of diabetic retinopathy, and a phenotyping characterization is recommendable to identify those patients in whom neuroprotective treatment might be of benefit. In recent years, a myriad of treatments based on neuroprotection have been tested in experimental models, but more interestingly, there are drugs with a dual activity (neuroprotective and vasculotropic). In this review, the recent evidence concerning the therapeutic approaches targeting neurovascular unit impairment will be presented, along with a critical review of the scientific gaps and problems which remain to be overcome before our knowledge can be transferred to clinical practice., This research was funded by grants from the Instituto de Salud Carlos III (DTS18/0163, PI19/01215, and ICI20/00129). The funders had no role in the design of the study; in the collection, analyses, or the interpretation of the data; in the writing of the manuscript, or in the decision to publish the results.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Local administration of porcine immunomodulatory, chemotactic and angiogenic extracellular vesicles using engineered cardiac scaffolds for myocardial infarction

  • Monguió-Tortajada, Marta|||0000-0003-2125-0810
  • Prat-Vidal, Cristina|||0000-0002-5621-1101
  • Font-Morón, Miriam|||0000-0002-4714-252X
  • Clos Sansalvador, Marta|||0000-0001-8522-7818
  • Calle Arias, Alexandra|||0000-0003-3903-5019
  • Gastelurrutia, Paloma|||0000-0001-6974-9210
  • Cserkóová, Adriana
  • Morancho, Anna|||0000-0001-9059-3206
  • Ramírez de Paz, Miguel Ángel|||0000-0002-5868-2134
  • Rosell Novel, Anna|||0000-0003-1082-3599
  • Bayés-Genís, Antoni|||0000-0002-3044-197X
  • Gálvez-Montón, Carolina|||0000-0003-2254-9371
  • Borràs i Serres, Francesc Enric|||0000-0003-4038-1912
  • Rudilla, F..
The administration of extracellular vesicles (EV) from mesenchymal stromal cells (MSC) is a promising cell-free nanotherapy for tissue repair after myocardial infarction (MI). However, the optimal EV delivery strategy remains undetermined. Here, we designed a novel MSC-EV delivery, using 3D scaffolds engineered from decellularised cardiac tissue as a cell-free product for cardiac repair. EV from porcine cardiac adipose tissue-derived MSC (cATMSC) were purified by size exclusion chromatography (SEC), functionally analysed and loaded to scaffolds. cATMSC-EV markedly reduced polyclonal proliferation and pro-inflammatory cytokines production (IFNγ, TNFα, IL12p40) of allogeneic PBMC. Moreover, cATMSC-EV recruited outgrowth endothelial cells (OEC) and allogeneic MSC, and promoted angiogenesis. Fluorescently labelled cATMSC-EV were mixed with peptide hydrogel, and were successfully retained in decellularised scaffolds. Then, cATMSC-EV-embedded pericardial scaffolds were administered in vivo over the ischemic myocardium in a pig model of MI. Six days from implantation, the engineered scaffold efficiently integrated into the post-infarcted myocardium. cATMSC-EV were detected within the construct and MI core, and promoted an increase in vascular density and reduction in macrophage and T cell infiltration within the damaged myocardium. The confined administration of multifunctional MSC-EV within an engineered pericardial scaffold ensures local EV dosage and release, and generates a vascularised bioactive niche for cell recruitment, engraftment and modulation of short-term post-ischemic inflammation.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Effect of Aging, Gender and Sensory Stimulation of TRPV1 Receptors with Capsaicin on Spontaneous Swallowing Frequency in Patients with Oropharyngeal Dysphagia, A Proof-of-Concept Study

  • Nascimento, Weslania Viviane|||0000-0003-1267-3475
  • Tomsen, Noemí|||0000-0001-7149-7948
  • Acedo, Saray
  • Campos Alcantara, Cristina
  • Cabib, Christopher|||0000-0002-1876-6923
  • Alvarez-Larruy, Marta
  • Clavé i Civit, Pere|||0000-0002-0696-8560
Spontaneous swallowing contributes to airway protection and depends on the activation of brainstem reflex circuits in the central pattern generator (CPG). We studied the effect of age and gender on spontaneous swallowing frequency (SSF) in healthy volunteers and assessed basal SSF and TRPV1 stimulation effect on SSF in patients with post-stroke oropharyngeal dysphagia (OD). The effect of age and gender on SSF was examined on 141 healthy adult volunteers (HV) divided into three groups: GI-18-39 yr, GII-40-59 yr, and GIII-.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Wharton's jelly mesenchymal stromal cells and derived extracellular vesicles as post-myocardial infarction therapeutic toolkit, an experienced view

  • Muñoz-Domínguez, Noelia
  • Roura, Santiago|||0000-0003-4063-9661
  • Prat-Vidal, Cristina|||0000-0002-5621-1101
  • Vives Armengol, Joaquim|||0000-0001-9719-5235
Outstanding progress has been achieved in developing therapeutic options for reasonably alleviating symptoms and prolonging the lifespan of patients suffering from myocardial infarction (MI). Current treatments, however, only partially address the functional recovery of post-infarcted myocardium, which is in fact the major goal for effective primary care. In this context, we largely investigated novel cell and TE tissue engineering therapeutic approaches for cardiac repair, particu-larly using multipotent mesenchymal stromal cells (MSC) and natural extracellular matrices, from pre-clinical studies to clinical application. A further step in this field is offered by MSC-derived extracellular vesicles (EV), which are naturally released nanosized lipid bilayer-delimited particles with a key role in cell-to-cell communication. Herein, in this review, we further describe and discuss the rationale, outcomes and challenges of our evidence-based therapy approaches using Wharton's jelly MSC and derived EV in post-MI management.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Study protocol for a randomised, double-blinded, placebo-controlled phase III trial examining the add-on efficacy, cost-utility and neurobiological effects of low-dose naltrexone (LDN) in patients with fibromyalgia (INNOVA study)

  • Colomer-Carbonell, Ariadna|||0000-0001-8923-6316
  • Sanabria-Mazo, Juan P.|||0000-0003-1688-435X
  • Hernández-Negrín, Halbert
  • Borràs, Xavier|||0000-0003-3972-1385
  • Suso-Ribera, Carlos|||0000-0002-2655-1017
  • García Palacios, Azucena|||0000-0001-9250-8714
  • Muchart, Jordi
  • Munuera, Josep|||0000-0001-5154-1796
  • D'Amico, Francesco|||0000-0001-7995-826X
  • Maes, Michael|||0000-0002-2012-871X
  • Younger, Jarred W.
  • Feliu-Soler, Albert|||0000-0003-2810-7670
  • Rozadilla-Sacanell, Antoni|||0000-0002-7555-189X
  • Luciano, Juan Vicente|||0000-0003-0750-1599
There is evidence that low-dose naltrexone (LDN; <5.0 mg/day) reduces pain and improves the quality of life of people with fibromyalgia syndrome (FMS). However, no randomised controlled trials with long-term follow-ups have been carried out. The INNOVA study will evaluate the add-on efficacy, safety, cost-utility and neurobiological effects of LDN for reducing pain in patients with FMS, with a 1-year follow-up. A single-site, prospective, randomised, double-blinded, placebo-controlled, parallel design phase III trial will be performed. Eligibility criteria include being adult, having a diagnosis of FMS and experiencing pain of 4 or higher on a 10-point numerical rating scale. Participants will be randomised to a LDN intervention group (4.5 mg/day) or to a placebo control group. Clinical assessments will be performed at baseline (T0), 3 months (T1), 6 months (T2) and 12 months (T3). The primary endpoint will be pain intensity. A sample size of 60 patients per study arm (120 in total), as calculated prior to recruitment for sufficient power, will be monitored between January 2022 and August 2024. Assessment will also include daily ecological momentary evaluations of FMS-related symptoms (eg, pain intensity, fatigue and sleep disturbance), and side effects via ecological momentary assessment through the Pain Monitor app during the first 3 months. Costs and quality-adjusted life years will be also calculated. Half of the participants in each arm will be scanned with MRI at T0 and T1 for changes in brain metabolites related to neuroinflammation and central sensitisation. Inflammatory biomarkers in serum will also be measured. This study has been approved by the Ethics Committee of the Fundació Sant Joan de Déu. The results will be actively disseminated through peer-reviewed journals, conference presentations, social media and community engagement activities. .
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Urine NMR-based TB metabolic fingerprinting for the diagnosis of TB in children

  • Comella-del-Barrio, Patricia|||0000-0002-2433-9864
  • Izquierdo-Garcia, José Luis
  • Gautier, Jacqueline
  • Doresca, Mariette Jean Coute
  • Campos-Olivas, Ramón|||0000-0002-5743-2221
  • Santiveri, Clara M.
  • Muriel-Moreno, Beatriz|||0000-0002-6683-9082
  • Prat i Aymerich, Cristina|||0000-0001-6974-9165
  • Abellana, Rosa|||0000-0003-4487-4431
  • Pérez-Porcuna, Tomás M.|||0000-0002-9951-7768
  • Cuevas, Luis E.|||0000-0002-6581-0587
  • Ruiz-Cabello, Jesús|||0000-0001-8681-5056
  • Domínguez, José|||0000-0001-7888-0309
Tuberculosis (TB) is a major cause of morbidity and mortality in children, and early diagnosis and treatment are crucial to reduce long-term morbidity and mortality. In this study, we explore whether urine nuclear magnetic resonance (NMR)-based metabolomics could be used to identify differences in the metabolic response of children with different diagnostic certainty of TB. We included 62 children with signs and symptoms of TB and 55 apparently healthy children. Six of the children with presumptive TB had bacteriologically confirmed TB, 52 children with unconfirmed TB, and 4 children with unlikely TB. Urine metabolic fingerprints were identified using high- and low-field proton NMR platforms and assessed with pattern recognition techniques such as principal components analysis and partial least squares discriminant analysis. We observed differences in the metabolic fingerprint of children with bacteriologically confirmed and unconfirmed TB compared to children with unlikely TB (p = 0.041 and p = 0.013, respectively). Moreover, children with unconfirmed TB with X-rays compatible with TB showed differences in the metabolic fingerprint compared to children with non-pathological X-rays (p = 0.009). Differences in the metabolic fingerprint in children with different diagnostic certainty of TB could contribute to a more accurate characterisation of TB in the paediatric population. The use of metabolomics could be useful to improve the prediction of TB progression and diagnosis in children.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Spontaneous Swallowing Frequency in Post-Stroke Patients with and Without Oropharyngeal Dysphagia, an Observational Study

  • Alvarez-Larruy, Marta
  • Tomsen, Noemí|||0000-0001-7149-7948
  • Guanyabens Busca, Nicolau|||0000-0002-2074-2744
  • Palomeras, Ernest|||0000-0002-0724-8653
  • Clavé i Civit, Pere|||0000-0002-0696-8560
  • Nascimento, Weslania Viviane|||0000-0003-1267-3475
Oropharyngeal dysphagia (OD) is a frequent complication after stroke (PSOD) that increases morbidity and mortality. Early detection of PSOD is essential to reduce morbidity and mortality in patients with acute stroke. In recent years, an association between reduced spontaneous swallowing frequency (SSF) and OD has been described. Likewise, the reduction of saliva substance P (SP) concentration has been associated with an increased risk of aspiration and a decrease in SSF. In this study we aimed to compare SSF, salivary SP concentration, hydration and nutritional status in post-stroke (PS) patients with and without OD. We included 45 acute PS patients (4.98 ± 2.80 days from stroke onset, 62.22% men, 71.78 ± 13.46 year). The Volume-Viscosity Swallowing Test (V-VST) was performed for clinical diagnosis of OD. SSF/minute was assessed through 10-min neurophysiological surface recordings including suprahyoid-electromyography and cricothyroid-accelerometry. Saliva samples were collected with a Salivette® to determine SP by ELISA. Hydration status was assessed by bioimpedance. Nutritional status was evaluated by Mini Nutritional Assessment Short Form (MNA-sf) and blood analysis. Twenty-seven PS patients (60%) had OD; 19 (40%), impaired safety of swallow. SSF was significantly reduced in PSOD, 0.23 ± 0.18 and PSOD with impaired safety, 0.22 ± 0.18 vs 0.48 ± 0.29 swallows/minute in PS without OD (PSnOD); (both p < 0.005). Nutritional risk was observed in 62.92% PSOD vs 11.11% PSnOD (p = 0.007) and visceral protein markers were also significantly reduced in PSOD (p < 0.05). Bioimpedance showed intracellular dehydration in 37.50% PSOD vs none in PSnOD. There were no differences for saliva SP concentrations. SSF is significantly reduced in PSOD in comparison with PSnOD. Acute PSOD patients present poor nutritional status, hydropenia, and high risk for respiratory complications.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

N-Glycans in Immortalized Mesenchymal Stromal Cell-Derived Extracellular Vesicles Are Critical for EV-Cell Interaction and Functional Activation of Endothelial Cells

  • Clos Sansalvador, Marta|||0000-0001-8522-7818
  • Garcia, Sergio G.|||0000-0001-7698-3734
  • Font-Morón, Miriam|||0000-0002-4714-252X
  • Williams, Charles
  • Reichardt, Niels-Christian
  • Falcón-Pérez, Juan M.|||0000-0003-3133-0670
  • Bayés-Genís, Antoni|||0000-0002-3044-197X
  • Roura, Santiago|||0000-0003-4063-9661
  • Franquesa, Marcella|||0000-0002-1287-8908
  • Monguió-Tortajada, Marta|||0000-0003-2125-0810
  • Borràs i Serres, Francesc Enric|||0000-0003-4038-1912
Mesenchymal stromal cell-derived extracellular vesicles (MSC-EV) are widely considered as a cell-free therapeutic alternative to MSC cell administration, due to their immunomodulatory and regenerative properties. However, the interaction mechanisms between EV and target cells are not fully understood. The surface glycans could be key players in EV-cell communication, being specific molecular recognition patterns that are still little explored. In this study, we focused on the role of N-glycosylation of MSC-EV as mediators of MSC-EV and endothelial cells' interaction for subsequent EV uptake and the induction of cell migration and angiogenesis. For that, EV from immortalized Wharton's Jelly MSC (iWJ-MSC-EV) were isolated by size exclusion chromatography (SEC) and treated with the glycosidase PNGase-F in order to remove wild-type N-glycans. Then, CFSE-labelled iWJ-MSC-EV were tested in the context of in vitro capture, agarose-spot migration and matrigel-based tube formation assays, using HUVEC. As a result, we found that the N-glycosylation in iWJ-MSC-EV is critical for interaction with HUVEC cells. iWJ-MSC-EV were captured by HUVEC, stimulating their tube-like formation ability and promoting their recruitment. Conversely, the removal of N-glycans through PNGase-F treatment reduced all of these functional activities induced by native iWJ-MSC-EV. Finally, comparative lectin arrays of iWJ-MSC-EV and PNGase-F-treated iWJ-MSC-EV found marked differences in the surface glycosylation pattern, particularly in N-acetylglucosamine, mannose, and fucose-binding lectins. Taken together, our results highlight the importance of N-glycans in MSC-EV to permit EV-cell interactions and associated functions.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Economic Evaluation of Clinical, Nutritional and Rehabilitation Interventions on Oropharyngeal Dysphagia after Stroke, A Systematic Review

  • Marin, Sergio|||0000-0001-7709-6504
  • Ortega, Omar|||0000-0001-6178-3748
  • Serra-Prat, Mateu|||0000-0002-6554-9913
  • Valls, Ester|||0000-0001-6536-8672
  • Pérez-Cordón, Laia|||0000-0002-1595-7759
  • Clavé i Civit, Pere|||0000-0002-0696-8560
Background: Post-stroke oropharyngeal dysphagia (PS-OD) and its complications increase healthcare costs, suggesting that its appropriate management is cost-effective. We aimed to assess the efficiency of healthcare interventions in PS-OD management. Methods: A systematic review was conducted following PRISMA recommendations. Four databases were searched from inception through 30 June 2021. Outcome measures were cost-effectiveness and cost-savings of healthcare interventions. English and Spanish literature were included. Narrative and tables were used to present and synthesise evidence. Quality was evaluated using the CHEERS Statement. Results: A total of 244 studies were identified, and 10 were included. Screening and diagnosis of PS-OD studies found: (1) adjusted reduction in hospitalisation costs when assessed during the first admission day; (2) non-significant reduction in hospitalisation costs with OD management after thrombolysis; and (3) videofluoroscopy as the most cost-effective screening method (compared to bedside evaluation and a combination of both). Two studies showed cost-effective rehabilitation programmes, including OD management. Pelczarska et al. showed an incremental cost-utility ratio of texture-modified diets using a gum-based thickener of 20,977 PLN (4660€) following a dynamic model, and Kotecki et al. commercially prepared thickened fluids that were 44% to 59% less expensive than in situ prepared fluids. Elia et al. showed home enteral nutrition was cost-effective (£12,817/QALY), and Beavan et al. showed higher nutrient intake and low increase in hospitalisation costs using looped-nasogastric tubes (£5.20 for every 1% increase). Heterogeneity between studies precluded a quantitative synthesis. Conclusions: Included studies suggest that healthcare interventions aiming to prevent OD complications are cost-effective. However, studies assessing novel strategies are needed.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Transcriptomic Analysis Reveals That Retinal Neuromodulation Is a Relevant Mechanism in the Neuroprotective Effect of Sitagliptin in an Experimental Model of Diabetic Retinopathy

  • Ramos, Hugo|||0000-0001-6443-7576
  • Bogdanov, Patricia|||0000-0003-0669-4958
  • Simó Canonge, Rafael|||0000-0003-0475-3096
  • Deàs Just, Anna|||0000-0002-3129-6313
  • Hernández, Cristina|||0000-0002-3109-1721
Synaptic dysfunction and neuronal damage have been extensively associated with diabetic retinopathy (DR). Our group evidenced that chronic hyperglycemia reduces the retinal expression of presynaptic proteins, which are crucial for proper synaptic function. The aim of the study was to explore the effect of topically administered sitagliptin, an inhibitor of the enzyme dipeptidyl peptidase-4, on the retinal expression patterns of an experimental model of DR. Transcriptome analysis was performed, comparing the retinas of 10 diabetic (db/db) mice randomly treated with sitagliptin eye drops (10 mg/mL) twice daily and the retinas of 10 additional db/db mice that received vehicle eye drops. Ten non-diabetic mice (db/+) were used as a control group. The Gene Ontology (GO) and Reactome databases were used to perform the gene set enrichment analysis (GSEA) in order to explore the most enriched biological pathways among the groups. The most differentiated genes of these pathways were validated through quantitative RT-PCR. Transcriptome analysis revealed that sitagliptin eye drops have a significant effect on retinal expression patterns and that neurotransmission is the most enriched biological process. Our study evidenced enriched pathways that contain genes involved in membrane trafficking, transmission across chemical synapses, vesicle-mediated transport, neurotransmitter receptors and postsynaptic signal transmission with negative regulation of signaling as a consequence of neuroprotector treatment with sitagliptin. This improves the modulation of the macromolecule biosynthetic process with positive regulation of cell communication, which provides beneficial effects for the neuronal metabolism. This study suggests that topical administration of sitagliptin ameliorates the abnormalities on presynaptic and postsynaptic signal transmission during experimental DR and that this improvement is one of the main mechanisms behind the previously demonstrated beneficial effects.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Acellular cardiac scaffolds enriched with MSC-derived extracellular vesicles limit ventricular remodelling and exert local and systemic immunomodulation in a myocardial infarction porcine model

  • Monguió-Tortajada, Marta|||0000-0003-2125-0810
  • Prat-Vidal, Cristina|||0000-0002-5621-1101
  • Martínez-Falguera, Daina|||0000-0002-9439-0542
  • Teis, Albert|||0000-0002-4820-0736
  • Soler-Botija, Carolina|||0000-0002-4584-9134
  • Courageux, Yvan|||0000-0002-1484-2677
  • Munizaga-Larroudé, Micaela
  • Font-Morón, Miriam|||0000-0002-4714-252X
  • Bayés-Genís, Antoni|||0000-0002-3044-197X
  • Borràs i Serres, Francesc Enric|||0000-0003-4038-1912
  • Rudilla, F..
  • Gálvez-Montón, Carolina|||0000-0003-2254-9371
Rationale: Extracellular vesicles (EVs) from mesenchymal stromal cell (MSC) are a potential therapy for cardiac healing after myocardial infarction (MI). Nevertheless, neither their efficient administration nor therapeutic mechanisms are fully elucidated. Here, we evaluate the preclinical efficacy of a tissue engineering approach to locally deliver porcine cardiac adipose tissue MSC-EV (cATMSC-EV) in an acute MI pig model. Methods: After MI by permanent ligation of the coronary artery, pigs (n = 24) were randomized to Untreated or treated groups with a decellularised pericardial scaffold filled with peptide hydrogel and cATMSC-EV purified by size exclusion chromatography (EV-Treated group) or buffer (Control group), placed over the post-infarcted myocardium. Results: After 30 days, cardiac MRI showed an improved cardiac function in EV-Treated animals, with significantly higher right ventricle ejection fraction (+20.8% in EV-Treated; p = 0.026), and less ventricle dilatation, indicating less myocardial remodelling. Scar size was reduced, with less fibrosis in the distal myocardium (-42.6% Col I in EV-Treated vs Untreated; p = 0.03), a 2-fold increase in vascular density (EV-Treated; p = 0.019) and less CCL2 transcription in the infarct core. EV-treated animals had less macrophage infiltration in the infarct core (-31.7% of CD163 + cells/field in EV-Treated; p = 0.026), but 5.8 times more expressing anti-inflammatory CD73 (p = 0.015). Systemically, locally delivered cATMSC-EV also triggered a systemic effect, doubling the circulating IL-1ra (p = 0.01), and reducing the PBMC rush 2d post-MI, the TNFα and GM-CSF levels at 30d post-MI, and modulating the CD73 + and CCR2 + monocyte populations, related to immunomodulation and fibrosis modulation. Conclusions: These results highlight the potential of cATMSC-EV in modulating hallmarks of ischemic injury for cardiac repair after MI.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Clinical translation of mesenchymal stromal cell extracellular vesicles, Considerations on scientific rationale and production requisites

  • Courageux, Yvan|||0000-0002-1484-2677
  • Monguió-Tortajada, Marta|||0000-0003-2125-0810
  • Prat-Vidal, Cristina|||0000-0002-5621-1101
  • Bayés-Genís, Antoni|||0000-0002-3044-197X
  • Roura, Santiago|||0000-0003-4063-9661
The present paper is a commentary to 'Identification and characterization of hADSC - derived exosome proteins from different isolation methods ' (Huang et al. 2021; ). Given the enthusiasm for the potential of mesenchymal stromal cell-derived extracellular vesicles (MSC-EVs), some considerations deserve attention as they move through successive stages of research and application into humans. We herein remark the prerequisite of generating that evidence ensuring a high consistency in safety, composition and biological activity of the intended MSC-EV preparations, and the suitability of disparate isolation techniques to produce efficacious EV preparations and fulfil requirements for standardized clinical-grade biomanufacturing.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Deep Learning Analyses to Delineate the Molecular Remodeling Process after Myocardial Infarction

  • Iborra Egea, Oriol|||0000-0002-7280-859X
  • Gálvez-Montón, Carolina|||0000-0003-2254-9371
  • Prat-Vidal, Cristina|||0000-0002-5621-1101
  • Rudilla, F
  • Soler-Botija, Carolina|||0000-0002-4584-9134
  • Revuelta-López, Elena|||0000-0001-8962-5936
  • Ferrer-Curriu, Gemma|||0000-0002-2651-649X
  • Segú-Vergés, Cristina|||0000-0002-8215-872X
  • Mellado-Bergillos, Araceli
  • Gomez-Puchades, Pol
  • Gastelurrutia, Paloma|||0000-0001-6974-9210
  • Bayés-Genís, Antoni|||0000-0002-3044-197X
Specific proteins and processes have been identified in post-myocardial infarction (MI) pathological remodeling, but a comprehensive understanding of the complete molecular evolution is lacking. We generated microarray data from swine heart biopsies at baseline and 6, 30, and 45 days after infarction to feed machine-learning algorithms. We cross-validated the results using available clinical and experimental information. MI progression was accompanied by the regulation of adipogenesis, fatty acid metabolism, and epithelial-mesenchymal transition. The infarct core region was enriched in processes related to muscle contraction and membrane depolarization. Angiogenesis was among the first morphogenic responses detected as being sustained over time, but other processes suggesting post-ischemic recapitulation of embryogenic processes were also observed. Finally, protein-triggering analysis established the key genes mediating each process at each time point, as well as the complete adverse remodeling response. We modeled the behaviors of these genes, generating a description of the integrative mechanism of action for MI progression. This mechanistic analysis overlapped at different time points; the common pathways between the source proteins and cardiac remodeling involved IGF1R, RAF1, KPCA, JUN, and PTN11 as modulators. Thus, our data delineate a structured and comprehensive picture of the molecular remodeling process, identify new potential biomarkers or therapeutic targets, and establish therapeutic windows during disease progression.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Circulating virome and inflammatory proteome in patients with ST-elevation myocardial infarction and primary ventricular fibrillation

  • Oliveras, Teresa
  • Revuelta-López, Elena|||0000-0001-8962-5936
  • Garcia Garcia, Cosme|||0000-0001-6330-1677
  • Cserkóová, Adriana
  • Rueda, Ferran|||0000-0001-5464-4870
  • Labata, Carlos|||0000-0002-4505-0787
  • Ferrer Vinardel, Marc|||0000-0002-1283-8578
  • Montero, Santiago|||0000-0002-0984-3472
  • El Ouaddi, Nabil|||0000-0002-5980-8915
  • Martínez, Maria José
  • Roura, Santiago|||0000-0003-4063-9661
  • Gálvez-Montón, Carolina|||0000-0003-2254-9371
  • Bayés-Genís, Antoni|||0000-0002-3044-197X
Primary ventricular fibrillation (PVF) is a life-threatening complication of ST-segment elevation myocardial infarction (STEMI). It is unclear what roles viral infection and/or systemic inflammation may play as underlying triggers of PVF, as a second hit in the context of acute ischaemia. Here we aimed to evaluate whether the circulating virome and inflammatory proteome were associated with PVF development in patients with STEMI. Blood samples were obtained from non-PVF and PVF STEMI patients at the time of primary PCI, and from non-STEMI healthy controls. The virome profile was analysed using VirCapSeq-VERT (Virome Capture Sequencing Platform for Vertebrate Viruses), a sequencing platform targeting viral taxa of 342,438 representative sequences, spanning all virus sequence records. The inflammatory proteome was explored with the Olink inflammation panel, using the Proximity Extension Assay technology. After analysing all viral taxa known to infect vertebrates, including humans, we found that non-PVF and PVF patients only significantly differed in the frequencies of viruses in the Gamma-herpesvirinae and Anelloviridae families. In particular, most showed a significantly higher relative frequency in non-PVF STEMI controls. Analysis of systemic inflammation revealed no significant differences between the inflammatory profiles of non-PVF and PVF STEMI patients. Inflammatory proteins associated with cell adhesion, chemotaxis, cellular response to cytokine stimulus, and cell activation proteins involved in immune response (IL6, IL8 CXCL-11, CCL-11, MCP3, MCP4, and ENRAGE) were significantly higher in STEMI patients than non-STEMI controls. CDCP1 and IL18-R1 were significantly higher in PVF patients compared to healthy subjects, but not compared to non-PVF patients. The circulating virome and systemic inflammation were not associated with increased risk of PVF development in acute STEMI. Accordingly, novel strategies are needed to elucidate putative triggers of PVF in the setting of acute ischaemia, in order to reduce STEMI-driven sudden death burden.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Exploring the Relationship Between Self-Compassion and Compassion for Others, The Role of Psychological Distress and Wellbeing

  • Garcia-Campayo, Javier|||0000-0002-3797-4218
  • Barcelo, Alberto|||0000-0002-2116-9257
  • Martínez-Rubio, David|||0000-0002-9346-3869
  • Navarrete Hidalgo, Jaime|||0000-0002-9482-4822
  • Pérez-Aranda, Adrián|||0000-0002-1602-3413
  • Feliu-Soler, Albert|||0000-0003-2810-7670
  • Luciano, Juan Vicente|||0000-0003-0750-1599
  • Baer, Ruth
  • Kuyken, Willem
  • Montero-Marín, Jesús|||0000-0001-5677-1662
We addressed construct validity and explored the relationship between self-compassion and compassion for others using the two main current operationalizations of compassion (Neff's and the Sussex-Oxford Compassion Scales, SOCSs). Relationships with psychological distress and wellbeing, and potential differences in the association between self-compassion and compassion for others by level of psychological distress and wellbeing were also explored. Participants (n = 811) completed the Spanish adaptations of the Self-Compassion Scale (SCS), the Compassion Scale (CS), the SOCSs (for the self/others), the Short Warwick-Edinburgh Mental Well-Being Scale (SWEMWBS), and the Depression Anxiety Stress Scales-21 (DASS-21). We fitted bifactor models to estimate the general factor of each construct for the different operationalizations, and calculated correlations between them. Relationships between self-compassion and compassion for others from the same operationalization were intermediate, while those between the same constructs from different operationalizations were large. Both constructs showed positive associations with wellbeing, while only self-compassion was associated with decreased psychological distress. Participants with good mental health showed higher associations between self-compassion and compassion for others than those with poorer mental health. Self-compassion and compassion for others appear to be dimensional constructs that can converge or diverge. When they converge, it is associated with better mental health.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Economic evaluation of videoconference group acceptance and commitment therapy and behavioral activation therapy for depression versus usual care among adults with chronic low back pain plus comorbid depressive symptoms

  • Sanabria-Mazo, Juan P.|||0000-0003-1688-435X
  • D'Amico, Francesco|||0000-0001-7995-826X
  • Cardeñosa, Eugenia|||0000-0002-9735-2269
  • Ferrer Forés, Maria Montserrat|||0000-0001-9867-7391
  • Edo Izquierdo, Sílvia|||0000-0002-6564-3475
  • Borràs, Xavier|||0000-0003-3972-1385
  • McCracken, Lance M.|||0000-0002-9734-0153
  • Feliu-Soler, Albert|||0000-0003-2810-7670
  • Sanz Ruiz, Antoni|||0000-0002-7952-4477
  • Luciano, Juan Vicente|||0000-0003-0750-1599
Chronic pain and depression are frequently comorbid conditions associated with significant healthcare and social costs.This study examined the cost-utility and cost-effectiveness of videoconference-based group forms of Acceptance and Commitment Therapy (ACT) and Behavioral Activation Therapy for Depression (BATD), as a complement to treatment-as-usual (TAU), for patients with chronic low back pain (CLBP) plus depressive symptoms, compared to TAU alone. A trial-based economic evaluation (n = 234) was conducted from a governmental and healthcare perspective with a time horizon of 12 months. Primary outcomes were the Brief Pain Inventory-Interference Scale (BPI-IS) and Quality Adjusted Life Year (QALY). Compared to TAU, ACT achieved a significant reduction in total costs (d = 0.47), and BATD achieved significant reductions in indirect (d = 0.61) and total costs (d = 0.63). Significant improvements in BPI-IS (d = 0.73 and d = 0.66, respectively) and QALY scores (d = 0.46 and d = 0.28, respectively) were found in ACT and BATD compared to TAU. No significant differences in costs and outcomes were found between ACT and BATD. In the intention-to-treat analyses, from the governmental and healthcare perspective, no significant differences in cost reduction and incremental effects were identified in the comparison between ACT, BATD, and TAU. However, in the complete case analysis, significant incremental effects of ACT (∆BPI-IS = -1.57 and -1.39, respectively) and BATD (∆BPI-IS = -1.08 and -1.04, respectively) compared with TAU were observed. In the per-protocol analysis, only the significant incremental effects of ACT (∆BPI-IS = -1.68 and -1.43, respectively) compared to TAU were detected. In conclusion, ACT and BATD might be efficient options in the management of CLBP plus comorbid depression symptoms as compared to usual care. However, no clear difference was found in the comparison between the two active therapies regarding cost-effectiveness or cost-utility. PERSPECTIVE: The economic evaluation of psychological therapies for the management of complex conditions is crucial as can be used in decision-making and resource allocation. This study provides evidence that videoconference group-based forms of ACT and BATD are more effective and involve a greater reduction in costs than usual care in the management of CLBP plus comorbid depressive symptoms. Both psychological therapies seem to offer good value for money to the Spanish national health service and the government.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Antioxidant Effects of DPP-4 Inhibitors in Early Stages of Experimental Diabetic Retinopathy

  • Ramos, Hugo|||0000-0001-6443-7576
  • Bogdanov, Patricia|||0000-0003-0669-4958
  • Huerta, Jordi|||0000-0002-9908-8051
  • Deàs Just, Anna|||0000-0002-3129-6313
  • Hernández, Cristina|||0000-0002-3109-1721
  • Simó Canonge, Rafael|||0000-0003-0475-3096
Hyperglycemia-induced oxidative stress plays a key role in the impairment of the retinal neurovascular unit, an early event in the pathogenesis of DR. The aim of this study was to assess the antioxidant properties of topical administration (eye drops) of sitagliptin in the diabetic retina. For this purpose, db/db mice received sitagliptin or vehicle eye drops twice per day for two weeks. Age-matched db/+ mice were used as the control group. We evaluated retinal mRNA (RT-PCR) and protein levels (Western blotting and immunohistochemistry) of different components from both the antioxidant system (NRF2, CAT, GPX, GR, CuZnSOD, and MnSOD) and the prooxidant machinery (PKC and TXNIP). We also studied superoxide levels (dihydroethidium staining) and oxidative damage to DNA/RNA (8-hydroxyguanosine immunostaining) and proteins (nitrotyrosine immunostaining). Finally, NF-кB translocation and IL-1β production were assessed through Western blotting and/or immunohistochemistry. We found that sitagliptin protected against diabetes-induced oxidative stress by reducing superoxide, TXNIP, PKC, and DNA/RNA/protein oxidative damage, and it prevented the downregulation of NRF2 and antioxidant enzymes, with the exception of catalase. Sitagliptin also exerted anti-inflammatory effects, avoiding both NF-кB translocation and IL-1β production. Sitagliptin prevents the diabetes-induced imbalance between ROS production and antioxidant defenses that occurs in diabetic retinas.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Neuromodulation Induced by Sitagliptin, A New Strategy for Treating Diabetic Retinopathy

  • Ramos, Hugo|||0000-0001-6443-7576
  • Bogdanov, Patricia|||0000-0003-0669-4958
  • Sabater, David|||0000-0001-8113-8594
  • Huerta, Jordi|||0000-0002-9908-8051
  • Valeri, Marta|||0000-0002-2011-203X
  • Hernández, Cristina|||0000-0002-3109-1721
  • Simó Canonge, Rafael|||0000-0003-0475-3096
Diabetic retinopathy (DR) involves progressive neurovascular degeneration of the retina. Reduction in synaptic protein expression has been observed in retinas from several diabetic animal models and human retinas. We previously reported that the topical administration (eye drops) of sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, prevented retinal neurodegeneration induced by diabetes in db/db mice. The aim of the present study is to examine whether the modulation of presynaptic proteins is a mechanism involved in the neuroprotective effect of sitagliptin. For this purpose, 12 db/db mice, aged 12 weeks, received a topical administration of sitagliptin (5 μL; concentration: 10 mg/mL) twice per day for 2 weeks, while other 12 db/db mice were treated with vehicle (5 μL). Twelve non-diabetic mice (db/+) were used as a control group. Protein levels were assessed by western blot and immunohistochemistry (IHC), and mRNA levels were evaluated by reverse transcription polymerase chain reaction (RT-PCR). Our results revealed a downregulation (protein and mRNA levels) of several presynaptic proteins such as synapsin I (Syn1), synaptophysin (Syp), synaptotagmin (Syt1), syntaxin 1A (Stx1a), vesicle-associated membrane protein 2 (Vamp2), and synaptosomal-associated protein of 25 kDa (Snap25) in diabetic mice treated with vehicle in comparison with non-diabetic mice. These proteins are involved in vesicle biogenesis, mobilization and docking, membrane fusion and recycling, and synaptic neurotransmission. Sitagliptin was able to significantly prevent the downregulation of all these proteins. We conclude that sitagliptin exerts beneficial effects in the retinas of db/db mice by preventing the downregulation of crucial presynaptic proteins. These neuroprotective effects open a new avenue for treating DR as well other retinal diseases in which neurodegeneration/synaptic abnormalities play a relevant role.
Dipòsit Digital de Documents de la UAB
Publication Artículo de revisión (ReviewArticle)

New Insights into Treating Early and Advanced Stage Diabetic Retinopathy

  • Simó Canonge, Rafael|||0000-0003-0475-3096
  • Hernández, Cristina|||0000-0002-3109-1721
Diabetic retinopathy (DR) is the leading cause of preventable blindness in the working-age population. The disease progresses slowly, and we can roughly differentiate two stages: early-stage (ESDR), in which there are mild retinal lesions and visual acuity is generally preserved, and advanced-stage (ASDR), in which the structural lesions are significant and visual acuity is compromised. At present, there are no specific treatments for ESDR and the current recommended action is to optimize metabolic control and maintain close control of blood pressure. However, in the coming years, it is foreseeable that therapeutic strategies based in neuroprotection will be introduced in the clinical arena. This means that screening aimed at identifying patients in whom neuroprotective treatment might be beneficial will be crucial. Regarding the treatment of ASDR, the current primary course is based on laser photocoagulation and intravitreal injections of anti-angiogenic factors or corticosteroids. Repeated intravitreal injections of anti-VEGF agents as the first-line treatment would be replaced by more cost-effective and personalized treatments based on the results of "liquid biopsies" of aqueous humor. Finally, topical administration (i.e., eye drops) of neuroprotective, anti-inflammatory and anti-angiogenic agents will represent a revolution in the treatment of DR in the coming decade. In this article, all these approaches and others will be critically discussed from a holistic perspective.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Economic evaluations of health care interventions in oropharyngeal dysphagia after stroke, protocol for a systematic review

  • Marin, Sergio|||0000-0001-7709-6504
  • Serra-Prat, Mateu|||0000-0002-6554-9913
  • Ortega, Omar|||0000-0001-6178-3748
  • Clavé i Civit, Pere|||0000-0002-0696-8560
Oropharyngeal dysphagia (OD) affects 40-81% of patients after stroke. A recent systematic review on the costs of OD and its main complications showed higher acute and long-term costs for those patients who developed OD, malnutrition and pneumonia after stroke. These results suggest that appropriate management of post-stroke OD could reduce clinical complications and costs. The purpose of this systematic review is to assess the available literature for healthcare interventions that are efficient or cost-effective in the management of OD. A systematic review on economic evaluations of health care interventions will be performed on post-stroke patients with OD following PRISMA recommendations. Four bibliographic databases will be searched and a subsequent reference check will be done. English and Spanish literature will be included without date restrictions. Studies will be included if they refer to economic evaluations or in which cost savings were reported in post-stroke patients suffering OD. Studies will be excluded if they are partial economic evaluation studies, if they refer to esophageal dysphagia, or if OD is caused by causes different from stroke. Evidence will be presented and synthetised with a narrative method and using tables. Quality evaluation will be done using the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. The protocol for this systematic review is the first step to assess the cost-effectiveness of the healthcare interventions that have been described as potential treatments for post-stroke OD. This systematic review will summarise the current evidence on the relation between cost and benefits associated with the appropriate management of OD in post-stroke patients. PROSPERO.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A Systematic and a Scoping Review on the Psychometrics and Clinical Utility of the Volume-Viscosity Swallow Test (V-VST) in the Clinical Screening and Assessment of Oropharyngeal Dysphagia

  • Riera, Stephanie|||0000-0003-4477-1248
  • Marin, Sergio|||0000-0001-7709-6504
  • Serra-Prat, Mateu|||0000-0002-6554-9913
  • Tomsen, Noemí|||0000-0001-7149-7948
  • Arreola, Viridiana|||0000-0003-3913-317X
  • Ortega, Omar|||0000-0001-6178-3748
  • Walshe, Margaret|||0000-0003-3924-8073
  • Clavé i Civit, Pere|||0000-0002-0696-8560
(1) Background: The volume-viscosity swallow test (V-VST) is a clinical tool for screening and diagnosis of oropharyngeal dysphagia (OD). Our aims were to examine the clinical utility of the V-VST against videofluoroscopy (VFS) or fiberoptic endoscopic evaluation of swallow (FEES) and to map the V-VST usage with patients at risk of OD across the years since it was described for the first time, carrying a systematic and a scoping review. (2) Methods: We performed both a systematic review (SR) including studies that look at the diagnostic test accuracy, and a scoping review (ScR) with articles published from September 2008 to May 2020. Searches were done in different databases, including PubMed and EMBASE from September 2008 until May 2020, and no language restrictions were applied. A meta-analysis was done in the SR to assess the psychometric properties of the V-VST. Quality of studies was assessed by Dutch Cochrane, QUADAS, GRADE (SR), and STROBE (ScR) criteria. The SR protocol was registered on PROSPERO (registration: CRD42020136252). (3) Results: For the diagnostic accuracy SR: four studies were included. V-VST had a diagnostic sensitivity for OD of 93.17%, 81.39% specificity, and an inter-rater reliability Kappa = 0.77. Likelihood ratios (LHR) for OD were 0.08 (LHR-) and 5.01 (LHR+), and the diagnostic odds ratio for OD was 51.18. Quality of studies in SR was graded as high with low risk of bias. In the ScR: 34 studies were retrieved. They indicated that V-VST has been used internationally to assess OD's prevalence and complications. (4) Conclusions: The V-VST has strong psychometric properties and valid endpoints for OD in different phenotypes of patients. Our results support its utility in the screening and clinical diagnosis and management of OD.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Psychometric examination of the Multidimensional Psychological Flexibility Inventory Short Form (MPFI-24) and the Psy-Flex Spanish versions in individuals with chronic pain

  • Navarrete Hidalgo, Jaime|||0000-0002-9482-4822
  • Rodríguez Freire, Carla|||0009-0006-6728-5778
  • Sanabria-Mazo, Juan P.|||0000-0003-1688-435X
  • Martínez-Rubio, David|||0000-0002-9346-3869
  • McCracken, Lance M.|||0000-0002-9734-0153
  • Gallego, Ana|||0000-0002-8060-2495
  • Sundström, Felicia T.A.|||0000-0002-7032-1614
  • Serrat López, Mayte|||0000-0002-5591-9407
  • Alonso, Jordi|||0000-0001-8627-9636
  • Feliu-Soler, Albert|||0000-0003-2810-7670
  • Nieto Luna, Rubén|||0000-0002-8759-319X
  • Luciano, Juan Vicente|||0000-0003-0750-1599
BACKGROUND: Acceptance and Commitment Therapy (ACT) has been found to be beneficial for individuals dealing with chronic pain. The theoretical mechanisms of change proposed by ACT are based on the Hexaflex model. To comprehensively reflect this model, the Multidimensional Psychological Flexibility Inventory (MPFI) and Psy-Flex have been developed. The study aimed to adapt the MPFI-24 and the Psy-Flex for Spanish-speaking populations with chronic pain and to examine their dimensionality, internal consistency, convergent validity and incremental validity. METHODS: This cross-sectional study involved 309 Spanish-speaking adults with chronic pain who completed an online survey. The majority of the participants were women (88.3%). The ages ranged from 18 to 79 years. RESULTS: Factor analysis showed that the Spanish version of the MPFI-24 has 12 factors, consisting of six flexibility and six inflexibility factors, similar to the original version, but lacking second-order general factors. The Psy-Flex demonstrated a single-factor structure, maintaining the general factor of psychological flexibility seen in the original version. The MPFI-24 showed good internal consistency and adequate convergent validity, with the exception of the Acceptance and Experiential Avoidance subscales. The Psy-Flex showed good internal consistency and convergent validity. Notably, both the MPFI-24 and Psy-Flex scores significantly explained additional variance in psychological distress beyond other ACT-related measures of Hexaflex processes; however, only the Psy-Flex explained pain interference. CONCLUSIONS: The Spanish adaptations of the MPFI-24 and Psy-Flex are valid and reliable instruments for assessing the Hexaflex model processes in Spanish-speaking adults with chronic pain. SIGNIFICANCE STATEMENT: Practitioners and researchers in chronic pain will find the Spanish versions of the MPFI-24 and the Psy-Flex here, along with recommendations for their use and scoring based on a robust psychometric rationale. It should be noted that these measures surpass the Chronic Pain Acceptance Questionnaire (CPAQ) and the Psychological Inflexibility in Pain Scale (PIPS), which are considered gold standards in chronic pain assessment.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Local administration of porcine immunomodulatory, chemotactic and angiogenic extracellular vesicles using engineered cardiac scaffolds for myocardial infarction

  • Moron-Font, Miriam
  • Clos-Sansalvador, Marta
  • Calle, Alexandra
  • Morancho Retana, Anna
  • Rosell Novel, Anna
  • Monguió-Tortajada, Marta
  • Prat-Vidal, Cristina
  • Gastelurrutia, Paloma
Ingeniería de tejido cardíaco; Exosomas; Infiltración, Enginyeria de teixits cardíacs; Exosomes; Infiltració, Cardiac tissue engineering; Exosomes; Infiltration, The administration of extracellular vesicles (EV) from mesenchymal stromal cells (MSC) is a promising cell-free nanotherapy for tissue repair after myocardial infarction (MI). However, the optimal EV delivery strategy remains undetermined. Here, we designed a novel MSC-EV delivery, using 3D scaffolds engineered from decellularised cardiac tissue as a cell-free product for cardiac repair. EV from porcine cardiac adipose tissue-derived MSC (cATMSC) were purified by size exclusion chromatography (SEC), functionally analysed and loaded to scaffolds. cATMSC-EV markedly reduced polyclonal proliferation and pro-inflammatory cytokines production (IFNγ, TNFα, IL12p40) of allogeneic PBMC. Moreover, cATMSC-EV recruited outgrowth endothelial cells (OEC) and allogeneic MSC, and promoted angiogenesis. Fluorescently labelled cATMSC-EV were mixed with peptide hydrogel, and were successfully retained in decellularised scaffolds. Then, cATMSC-EV-embedded pericardial scaffolds were administered in vivo over the ischemic myocardium in a pig model of MI. Six days from implantation, the engineered scaffold efficiently integrated into the post-infarcted myocardium. cATMSC-EV were detected within the construct and MI core, and promoted an increase in vascular density and reduction in macrophage and T cell infiltration within the damaged myocardium. The confined administration of multifunctional MSC-EV within an engineered pericardial scaffold ensures local EV dosage and release, and generates a vascularised bioactive niche for cell recruitment, engraftment and modulation of short-term post-ischemic inflammation., This work was supported in part by grants from Fundació la Marató de TV3 (201516-10, 201502-30), the PERIS (SLT002/16/00234) and SGR programmes (2017-SGR-301 REMAR Group, 2017-SGR-1427 and 2017-SGR-483 ICREC Group) from the Generalitat de Catalunya, the Spanish Ministry of Economy and Competitiveness-MICINN (SAF2017-84324-C2-1-R; PID2019-110137RB-I00; PID2019-107145RB-I00), Instituto de Salud Carlos III (PI17/01487, PIC18/00014, ICI19/00039, PI18/00256, PI18/01227, and ICI20/00135), ISCIII-REDinREN (RD16/0009 Feder Funds), Red de Terapia Celular-TerCel (RD16/0011/0006), CIBER Cardiovascular (CB16/11/00403) projects as a part of the Plan Nacional de I + D + I, and it was co-funded by ISCIII-Subdirección General de Evaluación y el Fondo Europeo de Desarrollo Regional (FEDER), AGAUR (2019PROD00122), Sociedad Española de Cardiología, Societat Catalana de Cardiologia, PCMR[C] and EoI Collaborative Projects on Regenerative Medicine 2019, and Institut Català de Salut (ICS). PG is sponsored by the PERIS (SLT002/16/00209) from the Generalitat de Catalunya. AR is supported by the Miguel Servet program (CPII15/00003) and research grants (PI16/00981) from the Instituto de Salud Carlos III, and co-financed by the European Regional Development Fund. FEB is a researcher from Fundació Institut de Recerca en Ciències de la Salut Germans Trias i Pujol, supported by the Health Department of the Catalan Government (Generalitat de Catalunya).
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Neuromodulation Induced by Sitagliptin: A New Strategy for Treating Diabetic Retinopathy

  • Ramos Abellán, Hugo
  • Bogdanov Baruj, Patricia
  • Huerta Alonso, Jordi
  • Valeri Sala, Marta
  • Hernández Pascual, Cristina
  • Simó Canonge, Rafael
  • Sabater Martínez, David
Presynaptic proteins; Retinal neurodegeneration; Sitagliptin, Proteínas presinápticas; Neurodegeneración retiniana; Sitagliptina, Proteïnes presinàptiques; Neurodegeneració retiniana; Sitagliptina, Diabetic retinopathy (DR) involves progressive neurovascular degeneration of the retina. Reduction in synaptic protein expression has been observed in retinas from several diabetic animal models and human retinas. We previously reported that the topical administration (eye drops) of sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, prevented retinal neurodegeneration induced by diabetes in db/db mice. The aim of the present study is to examine whether the modulation of presynaptic proteins is a mechanism involved in the neuroprotective effect of sitagliptin. For this purpose, 12 db/db mice, aged 12 weeks, received a topical administration of sitagliptin (5 μL; concentration: 10 mg/mL) twice per day for 2 weeks, while other 12 db/db mice were treated with vehicle (5 μL). Twelve non-diabetic mice (db/+) were used as a control group. Protein levels were assessed by western blot and immunohistochemistry (IHC), and mRNA levels were evaluated by reverse transcription polymerase chain reaction (RT-PCR). Our results revealed a downregulation (protein and mRNA levels) of several presynaptic proteins such as synapsin I (Syn1), synaptophysin (Syp), synaptotagmin (Syt1), syntaxin 1A (Stx1a), vesicle-associated membrane protein 2 (Vamp2), and synaptosomal-associated protein of 25 kDa (Snap25) in diabetic mice treated with vehicle in comparison with non-diabetic mice. These proteins are involved in vesicle biogenesis, mobilization and docking, membrane fusion and recycling, and synaptic neurotransmission. Sitagliptin was able to significantly prevent the downregulation of all these proteins. We conclude that sitagliptin exerts beneficial effects in the retinas of db/db mice by preventing the downregulation of crucial presynaptic proteins. These neuroprotective effects open a new avenue for treating DR as well other retinal diseases in which neurodegeneration/synaptic abnormalities play a relevant role., This research was funded by grants from the Ministerio de Economía y Competitividad (PID2019-104225RB-I00) and the Instituto de Salud Carlos III (DTS18/0163, PI19/01215, and ICI20/00129). The study funder was not involved in the design of the study.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Transcriptomic Analysis Reveals That Retinal Neuromodulation Is a Relevant Mechanism in the Neuroprotective Effect of Sitagliptin in an Experimental Model of Diabetic Retinopathy

  • Ramos Abellán, Hugo
  • Bogdanov Baruj, Patricia
  • Deàs Just, Anna
  • Hernández Buñuel, Cristina
  • Simó Canonge, Rafael
Diabetic retinopathy; Sitagliptin; Synaptic signal transmission, Retinopatia diabètica; Sitagliptina; Transmissió del senyal sinàptic, Retinopatía diabética; Sitagliptina; Transmisión de señal sináptica, Synaptic dysfunction and neuronal damage have been extensively associated with diabetic retinopathy (DR). Our group evidenced that chronic hyperglycemia reduces the retinal expression of presynaptic proteins, which are crucial for proper synaptic function. The aim of the study was to explore the effect of topically administered sitagliptin, an inhibitor of the enzyme dipeptidyl peptidase-4, on the retinal expression patterns of an experimental model of DR. Transcriptome analysis was performed, comparing the retinas of 10 diabetic (db/db) mice randomly treated with sitagliptin eye drops (10 mg/mL) twice daily and the retinas of 10 additional db/db mice that received vehicle eye drops. Ten non-diabetic mice (db/+) were used as a control group. The Gene Ontology (GO) and Reactome databases were used to perform the gene set enrichment analysis (GSEA) in order to explore the most enriched biological pathways among the groups. The most differentiated genes of these pathways were validated through quantitative RT-PCR. Transcriptome analysis revealed that sitagliptin eye drops have a significant effect on retinal expression patterns and that neurotransmission is the most enriched biological process. Our study evidenced enriched pathways that contain genes involved in membrane trafficking, transmission across chemical synapses, vesicle-mediated transport, neurotransmitter receptors and postsynaptic signal transmission with negative regulation of signaling as a consequence of neuroprotector treatment with sitagliptin. This improves the modulation of the macromolecule biosynthetic process with positive regulation of cell communication, which provides beneficial effects for the neuronal metabolism. This study suggests that topical administration of sitagliptin ameliorates the abnormalities on presynaptic and postsynaptic signal transmission during experimental DR and that this improvement is one of the main mechanisms behind the previously demonstrated beneficial effects., This research was funded by grants from the Ministerio de Economía y Competitividad (PID2019-104225RB-I00) and the Instituto de Salud Carlos III (DTS18/0163, PI19/01215 and ICI20/00129). The study funder was not involved in the design of the study.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Neurovascular Unit: A New Target for Treating Early Stages of Diabetic Retinopathy

  • Simó Servat, Olga
  • Bogdanov Baruj, Patricia
  • Hernández Pascual, Cristina
  • Simó Canonge, Rafael
Retinopatía diabética; Neurodegeneración; Unidad neurovascular, Retinopatia diabètica; Neurodegeneració; Unitat neurovascular, Diabetic retinopathy; Neurodegeneration; Neurovascular unit, The concept of diabetic retinopathy as a microvascular disease has evolved and is now considered a more complex diabetic complication in which neurovascular unit impairment plays an essential role and, therefore, can be considered as a main therapeutic target in the early stages of the disease. However, neurodegeneration is not always the apparent primary event in the natural story of diabetic retinopathy, and a phenotyping characterization is recommendable to identify those patients in whom neuroprotective treatment might be of benefit. In recent years, a myriad of treatments based on neuroprotection have been tested in experimental models, but more interestingly, there are drugs with a dual activity (neuroprotective and vasculotropic). In this review, the recent evidence concerning the therapeutic approaches targeting neurovascular unit impairment will be presented, along with a critical review of the scientific gaps and problems which remain to be overcome before our knowledge can be transferred to clinical practice., This research was funded by grants from the Instituto de Salud Carlos III (DTS18/0163, PI19/01215, and ICI20/00129). The funders had no role in the design of the study; in the collection, analyses, or the interpretation of the data; in the writing of the manuscript, or in the decision to publish the results.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Minimum Effective Dose of DPP-4 Inhibitors for Treating Early Stages of Diabetic Retinopathy in an Experimental Model

  • Bogdanov Baruj, Patricia
  • Ramos Abellán, Hugo
  • Valeri Sala, Marta
  • Deàs Just, Anna
  • Huerta Alonso, Jordi
  • Hernández Pascual, Cristina
  • Simó Canonge, Rafael
Dipeptidyl peptidase-4 inhibitors; Experimental diabetes; Retinal neurodegeneration, Inhibidores de la dipeptidil peptidasa-4; Diabetes experimental; Neurodegeneración retiniana, Inhibidors de la dipeptidil peptidasa-4; Diabetis experimental; Neurodegeneració de la retina, The neurovascular unit (NVU) plays an essential role in the development of diabetic retinopathy (DR). We previously reported that the topical administration (eye drops) of sitagliptin and saxagliptin, two dipeptidyl peptidase-4 inhibitors (DPP-4i), prevents retinal neurodegeneration and vascular leakage in db/db mice. The aim of the present study is to evaluate the minimum effective dose of the topical administration of these DPP-4i. For this purpose, sitagliptin and saxagliptin were tested at different concentrations (sitagliptin: 1 mg/mL, 5 and 10 mg/mL, twice per day; saxagliptin: 1 and 10 mg/mL, once or twice per day) in db/db mice. As end points of efficacy, the hallmarks of NVU impairment were evaluated: reactive gliosis, neural apoptosis, and vascular leakage. These parameters were assessed by immunohistochemistry, cell counting, and the Evans blue method, respectively. Our results demonstrated that the minimum effective dose is 5 mg/mL twice per day for sitagliptin, and 10 mg/mL twice per day for saxagliptin. In conclusion, this study provides useful results for the design of future preclinical regulatory studies and for planning clinical trials., This research was funded by grants from the Ministerio de Economía y Competitividad (PID2019-104225RB-I00) and the Instituto de Salud Carlos III (DTS18/0163, PI19/01215 and ICI20/00129). The study funder was not involved in the design of the study.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Ocular and Plasma Pharmacokinetics of Sitagliptin Eye Drops: Preclinical Data

  • Létondor, Anne
  • Ramos Abellán, Hugo
  • Simó Canonge, Rafael
  • Hernandez, Cristina
Eye drops; Pharmacokinetics; Sitagliptin, Gotas oftálmicas; Farmacocinética; Sitagliptina, Gotes oftàlmiques; Farmacocinètica; Sitagliptina, Background/Objectives: Early stages of diabetic retinopathy are currently considered an unmet medical need due to the lack of effective treatments beyond proper monitoring and control of glycemia and blood pressure. Sitagliptin eye drops have emerged as a new therapeutic approach against early stages of the disease, as they can prevent its main hallmarks, including both neurodegeneration and microvascular impairment. Interestingly, all of these effects occur without any glycemic systemic improvement. In the present study, we aimed to investigate the pharmacokinetics and distribution of the drug within the eye and plasma. Methods: A total of 48 male New Zealand rabbits were treated with topical administration (eye drops) of sitagliptin at two concentrations: 5 mg/mL and 10 mg/mL. Blood, iris/ciliary body, retina/choroid, aqueous humor, and vitreous humor samples were collected at specific intervals post-administration (10 and 30 min and 1, 3, 6, 15, and 24 h), processed, and analyzed using an LC-MS/MS method. The pharmacokinetics of sitagliptin were then calculated, and statistical comparisons were performed. Results: Our findings indicate that sitagliptin reaches the retina prior to the aqueous and vitreous humors, suggesting that its absorption follows the transscleral route. Additionally, systemic absorption was minimal and below pharmacologically active concentrations. Conclusions: These results support the use of an eye drop formulation for the treatment of diabetic retinopathy and other retinal diseases., This research was funded by a grant from the Instituto de Salud Carlos III (ICI20/00129).